| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA3 MYH11 VWA8 MYO7B CFTR ATP9B HSPA13 BPTF MDN1 ABCC8 DHX35 RFT1 ASCC3 DSCC1 CARNS1 DNAH9 DYNC1H1 PMS1 EP400 ATG7 DYNC2H1 DDX52 SMARCAL1 ATP13A5 ATP13A2 DNAH12 DNAH17 MYH15 ATP1A4 | 2.28e-07 | 614 | 320 | 29 | GO:0140657 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.73e-06 | 37 | 320 | 7 | GO:0045505 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 7.40e-06 | 18 | 320 | 5 | GO:0008569 | |
| GeneOntologyMolecularFunction | protein kinase activity | CDK16 CDK17 CDK18 HK1 MYLK ATR STK17A OBSCN CHEK1 CDK14 MAPK12 DSTYK MAP3K15 FLT1 CAD KALRN NTRK1 HTATIP2 LRRK1 ZAP70 PIM3 IGF1R MAP4K5 PKN2 | 4.06e-05 | 600 | 320 | 24 | GO:0004672 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 7.44e-05 | 28 | 320 | 5 | GO:0051959 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | CDK16 CDK17 CDK18 HK1 MYLK ATR STK17A OBSCN CHEK1 CDK14 MAPK12 PI4KB DSTYK MAP3K15 FLT1 CAD KALRN NTRK1 HTATIP2 HKDC1 LRRK1 ZAP70 PIM3 IGF1R MAP4K5 PKN2 | 8.22e-05 | 709 | 320 | 26 | GO:0016773 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA3 VWA8 CFTR ATP9B HSPA13 MDN1 ABCC8 DHX35 ASCC3 CARNS1 DNAH9 DYNC1H1 PMS1 DYNC2H1 DDX52 ATP13A5 ATP13A2 DNAH12 ATP1A4 | 9.99e-05 | 441 | 320 | 19 | GO:0016887 |
| GeneOntologyMolecularFunction | kinase activity | CDK16 CDK17 CDK18 HK1 MYLK ATR STK17A OBSCN CHEK1 CDK14 MAPK12 PI4KB DSTYK MAP3K15 FLT1 CAD KALRN NTRK1 HTATIP2 HKDC1 PI4KAP2 LRRK1 ZAP70 PIM3 IGF1R MAP4K5 PKN2 | 1.11e-04 | 764 | 320 | 27 | GO:0016301 |
| GeneOntologyMolecularFunction | calcium ion binding | MATN1 TRPM2 ADGRV1 TBC1D9 ITPR2 HMCN2 CRNN PLSCR3 SLC25A23 PLS3 CACNA1E VLDLR CAPS RCVRN PCDHB2 PCDHA12 SCGN LCP1 CRB1 EDEM3 THBS1 THBS4 CELSR2 EFCC1 EPDR1 MAN1B1 | 1.97e-04 | 749 | 320 | 26 | GO:0005509 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | CDK16 CDK17 CDK18 HK1 MYLK ATR STK17A OBSCN CHEK1 CDK14 KARS1 MAPK12 PI4KB DSTYK MAP3K15 UAP1L1 FLT1 CAD KALRN NTRK1 HTATIP2 HKDC1 POLE4 PI4KAP2 LRRK1 ZAP70 PIM3 IGF1R MAP4K5 PKN2 | 2.64e-04 | 938 | 320 | 30 | GO:0016772 |
| GeneOntologyMolecularFunction | protein serine kinase activity | CDK16 CDK17 CDK18 ATR STK17A OBSCN CHEK1 CDK14 MAPK12 DSTYK MAP3K15 KALRN LRRK1 PIM3 MAP4K5 PKN2 | 2.72e-04 | 363 | 320 | 16 | GO:0106310 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | CDK16 CDK17 CDK18 MYLK ATR STK17A OBSCN CHEK1 CDK14 MAPK12 DSTYK MAP3K15 KALRN HTATIP2 LRRK1 PIM3 MAP4K5 PKN2 | 3.36e-04 | 446 | 320 | 18 | GO:0004674 |
| GeneOntologyMolecularFunction | structural constituent of muscle | 5.99e-04 | 43 | 320 | 5 | GO:0008307 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 6.34e-04 | 118 | 320 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | Pyrin domain binding | 7.60e-04 | 3 | 320 | 2 | GO:0032090 | |
| Domain | ATPase_dyneun-rel_AAA | 5.99e-08 | 14 | 316 | 6 | IPR011704 | |
| Domain | AAA_5 | 5.99e-08 | 14 | 316 | 6 | PF07728 | |
| Domain | ARM-type_fold | CLTCL1 ATR MIF4GD UNC45A ITPR2 PLAA PDS5A HECTD1 FMNL1 HEATR4 ARMC9 PPP4R3A PPP4R3B UPF2 ARID2 PKP3 VPS35 EFR3B NUP188 DAAM1 STAG2 | 3.56e-07 | 339 | 316 | 21 | IPR016024 |
| Domain | TPR-like_helical_dom | CLTCL1 ATR SRP68 UNC45A FEM1C SMYD4 CFAP54 TONSL PEX5 ST13P4 OGT TRAPPC12 CAPN7 LONRF3 CFAP46 | 1.09e-05 | 233 | 316 | 15 | IPR011990 |
| Domain | GPR107-like | 1.90e-05 | 4 | 316 | 3 | IPR009637 | |
| Domain | Lung_7-TM_R | 1.90e-05 | 4 | 316 | 3 | PF06814 | |
| Domain | Protein_kinase_ATP_BS | CDK16 CDK17 CDK18 MYLK STK17A OBSCN CHEK1 CDK14 MAPK12 DSTYK MAP3K15 FLT1 KALRN NTRK1 ZAP70 PIM3 IGF1R MAP4K5 PKN2 | 2.69e-05 | 379 | 316 | 19 | IPR017441 |
| Domain | - | CLTCL1 ATR SRP68 UNC45A FEM1C SMYD4 CFAP54 TONSL PEX5 OGT TRAPPC12 LONRF3 CFAP46 | 5.41e-05 | 207 | 316 | 13 | 1.25.40.10 |
| Domain | AAA_8 | 7.04e-05 | 14 | 316 | 4 | PF12780 | |
| Domain | Dynein_heavy_chain_D4_dom | 7.04e-05 | 14 | 316 | 4 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 7.04e-05 | 14 | 316 | 4 | IPR013602 | |
| Domain | DHC_N2 | 7.04e-05 | 14 | 316 | 4 | PF08393 | |
| Domain | DHC_fam | 9.47e-05 | 15 | 316 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 9.47e-05 | 15 | 316 | 4 | PF03028 | |
| Domain | Dynein_heavy_dom | 9.47e-05 | 15 | 316 | 4 | IPR004273 | |
| Domain | PROTEIN_KINASE_ATP | CDK16 CDK17 CDK18 MYLK STK17A OBSCN CHEK1 CDK14 MAPK12 DSTYK MAP3K15 FLT1 KALRN NTRK1 LRRK1 ZAP70 PIM3 IGF1R MAP4K5 PKN2 | 1.16e-04 | 459 | 316 | 20 | PS00107 |
| Domain | Kinase-like_dom | CDK16 CDK17 CDK18 MYLK ATR STK17A OBSCN CHEK1 CDK14 MAPK12 PI4KB DSTYK MAP3K15 FLT1 KALRN NTRK1 LRRK1 ZAP70 PIM3 IGF1R MAP4K5 PKN2 | 1.49e-04 | 542 | 316 | 22 | IPR011009 |
| Domain | L_dom-like | NLRP7 LGR4 ERBIN TLR8 TONSL NTRK1 LRRK1 NLRP2 PPP1R7 NLRP14 IGF1R LGI2 LRRCC1 SNRPA1 LRRC71 LRRC74B | 1.58e-04 | 328 | 316 | 16 | IPR032675 |
| Domain | AAA+_ATPase | ABCA3 VWA8 CFTR MDN1 ABCC8 ASCC3 DNAH9 DYNC1H1 DYNC2H1 DNAH12 | 1.73e-04 | 144 | 316 | 10 | IPR003593 |
| Domain | AAA | ABCA3 VWA8 CFTR MDN1 ABCC8 ASCC3 DNAH9 DYNC1H1 DYNC2H1 DNAH12 | 1.73e-04 | 144 | 316 | 10 | SM00382 |
| Domain | ARM-like | ATR UNC45A PLAA PDS5A HECTD1 HEATR4 ARMC9 PPP4R3A PPP4R3B ARID2 PKP3 EFR3B DAAM1 STAG2 | 2.17e-04 | 270 | 316 | 14 | IPR011989 |
| Domain | Leu-rich_rpt | LGR4 ERBIN TLR8 TONSL NTRK1 LRRK1 NLRP2 PPP1R7 NLRP14 LGI2 LRRCC1 SNRPA1 LRRC71 LRRC74B | 2.26e-04 | 271 | 316 | 14 | IPR001611 |
| Domain | DHC_N1 | 2.52e-04 | 8 | 316 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 2.52e-04 | 8 | 316 | 3 | IPR013594 | |
| Domain | Prot_kinase_dom | CDK16 CDK17 CDK18 MYLK STK17A OBSCN CHEK1 CDK14 MAPK12 DSTYK MAP3K15 FLT1 KALRN NTRK1 LRRK1 ZAP70 PIM3 IGF1R MAP4K5 PKN2 | 2.68e-04 | 489 | 316 | 20 | IPR000719 |
| Domain | SMK-1 | 2.85e-04 | 2 | 316 | 2 | PF04802 | |
| Domain | DUF625 | 2.85e-04 | 2 | 316 | 2 | IPR006887 | |
| Domain | PROTEIN_KINASE_DOM | CDK16 CDK17 CDK18 MYLK STK17A OBSCN CHEK1 CDK14 MAPK12 DSTYK MAP3K15 FLT1 KALRN NTRK1 LRRK1 ZAP70 PIM3 IGF1R MAP4K5 PKN2 | 2.98e-04 | 493 | 316 | 20 | PS50011 |
| Domain | RA | 3.29e-04 | 36 | 316 | 5 | PF00788 | |
| Domain | - | NLRP7 LGR4 ERBIN TLR8 TONSL NTRK1 LRRK1 NLRP2 PPP1R7 NLRP14 LGI2 LRRCC1 SNRPA1 LRRC71 LRRC74B | 3.99e-04 | 321 | 316 | 15 | 3.80.10.10 |
| Domain | Ser/Thr_kinase_AS | CDK16 CDK17 CDK18 MYLK STK17A OBSCN CHEK1 CDK14 MAPK12 DSTYK MAP3K15 KALRN LRRK1 PIM3 MAP4K5 PKN2 | 4.09e-04 | 357 | 316 | 16 | IPR008271 |
| Domain | - | ABCA3 NLRP7 VWA8 MYO7B CFTR MDN1 ABCC8 GNA12 DHX35 ASCC3 HS3ST4 DNAH9 DYNC1H1 NDST1 NWD1 EP400 DYNC2H1 MTHFD1L DDX52 SMARCAL1 LRRK1 NLRP2 NLRP14 DNAH12 WSCD2 TJP3 | 4.21e-04 | 746 | 316 | 26 | 3.40.50.300 |
| Domain | Laminin_G | 4.32e-04 | 58 | 316 | 6 | IPR001791 | |
| Domain | S_TKc | CDK16 CDK17 CDK18 MYLK STK17A OBSCN CHEK1 CDK14 MAPK12 DSTYK MAP3K15 KALRN LRRK1 PIM3 MAP4K5 PKN2 | 4.34e-04 | 359 | 316 | 16 | SM00220 |
| Domain | PROTEIN_KINASE_ST | CDK16 CDK17 CDK18 MYLK STK17A OBSCN CHEK1 CDK14 MAPK12 DSTYK MAP3K15 KALRN LRRK1 PIM3 MAP4K5 PKN2 | 4.75e-04 | 362 | 316 | 16 | PS00108 |
| Domain | VWFA | 4.77e-04 | 82 | 316 | 7 | PS50234 | |
| Domain | RA_dom | 5.44e-04 | 40 | 316 | 5 | IPR000159 | |
| Domain | ACTININ_2 | 5.52e-04 | 23 | 316 | 4 | PS00020 | |
| Domain | ACTININ_1 | 5.52e-04 | 23 | 316 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 5.52e-04 | 23 | 316 | 4 | IPR001589 | |
| Domain | VWA | 5.52e-04 | 84 | 316 | 7 | SM00327 | |
| Domain | P-loop_NTPase | ABCA3 MYH11 NLRP7 VWA8 MYO7B CFTR MDN1 ABCC8 GNA12 DHX35 ASCC3 HS3ST4 DNAH9 DYNC1H1 NDST1 NWD1 EP400 DYNC2H1 MTHFD1L DDX52 SMARCAL1 LRRK1 NLRP2 NLRP14 DNAH12 WSCD2 MYH15 TJP3 | 5.95e-04 | 848 | 316 | 28 | IPR027417 |
| Domain | U2A'_phosphoprotein32A_C | 7.16e-04 | 11 | 316 | 3 | IPR003603 | |
| Domain | LRRcap | 7.16e-04 | 11 | 316 | 3 | SM00446 | |
| Domain | Pkinase | CDK16 CDK17 CDK18 MYLK STK17A OBSCN CHEK1 CDK14 MAPK12 DSTYK MAP3K15 KALRN LRRK1 PIM3 MAP4K5 PKN2 | 8.23e-04 | 381 | 316 | 16 | PF00069 |
| Domain | RMMBL | 8.47e-04 | 3 | 316 | 2 | IPR011108 | |
| Domain | Lactamase_B_6 | 8.47e-04 | 3 | 316 | 2 | PF16661 | |
| Domain | RMMBL | 8.47e-04 | 3 | 316 | 2 | PF07521 | |
| Domain | - | 1.15e-03 | 95 | 316 | 7 | 2.60.120.200 | |
| Domain | Lactamase_B | 1.21e-03 | 13 | 316 | 3 | PF00753 | |
| Domain | VWF_A | 1.46e-03 | 99 | 316 | 7 | IPR002035 | |
| Domain | ATP_GRASP | 1.52e-03 | 14 | 316 | 3 | PS50975 | |
| Domain | MT | 1.52e-03 | 14 | 316 | 3 | PF12777 | |
| Domain | uDENN | 1.52e-03 | 14 | 316 | 3 | SM00800 | |
| Domain | Dynein_HC_stalk | 1.52e-03 | 14 | 316 | 3 | IPR024743 | |
| Domain | ATP-grasp | 1.52e-03 | 14 | 316 | 3 | IPR011761 | |
| Domain | TRPM_tetra | 1.67e-03 | 4 | 316 | 2 | PF16519 | |
| Domain | Beta-Casp | 1.67e-03 | 4 | 316 | 2 | SM01027 | |
| Domain | Beta-Casp | 1.67e-03 | 4 | 316 | 2 | PF10996 | |
| Domain | TRPM_tetra | 1.67e-03 | 4 | 316 | 2 | IPR032415 | |
| Domain | Beta_Casp | 1.67e-03 | 4 | 316 | 2 | IPR022712 | |
| Domain | DUF21 | 1.67e-03 | 4 | 316 | 2 | PF01595 | |
| Domain | DUF21 | 1.67e-03 | 4 | 316 | 2 | IPR002550 | |
| Domain | P5-ATPase | 1.67e-03 | 4 | 316 | 2 | PF12409 | |
| Domain | ATP_grasp_subdomain_2 | 1.76e-03 | 31 | 316 | 4 | IPR013816 | |
| Domain | Lactamase_B | 1.88e-03 | 15 | 316 | 3 | SM00849 | |
| Domain | uDENN | 1.88e-03 | 15 | 316 | 3 | PF03456 | |
| Domain | - | 1.99e-03 | 32 | 316 | 4 | 3.40.1110.10 | |
| Domain | - | 1.99e-03 | 32 | 316 | 4 | 2.70.150.10 | |
| Domain | TPR | 2.03e-03 | 165 | 316 | 9 | PS50005 | |
| Domain | TPR_REGION | 2.03e-03 | 165 | 316 | 9 | PS50293 | |
| Domain | UDENN | 2.28e-03 | 16 | 316 | 3 | PS50946 | |
| Domain | DDENN | 2.28e-03 | 16 | 316 | 3 | PS50947 | |
| Domain | dDENN | 2.28e-03 | 16 | 316 | 3 | SM00801 | |
| Domain | DENN | 2.28e-03 | 16 | 316 | 3 | SM00799 | |
| Domain | DENN | 2.28e-03 | 16 | 316 | 3 | PF02141 | |
| Domain | dDENN | 2.28e-03 | 16 | 316 | 3 | PF03455 | |
| Domain | dDENN_dom | 2.28e-03 | 16 | 316 | 3 | IPR005112 | |
| Domain | uDENN_dom | 2.28e-03 | 16 | 316 | 3 | IPR005113 | |
| Domain | DENN | 2.28e-03 | 16 | 316 | 3 | PS50211 | |
| Domain | DENN_dom | 2.28e-03 | 16 | 316 | 3 | IPR001194 | |
| Domain | LRR_6 | 2.34e-03 | 55 | 316 | 5 | PF13516 | |
| Domain | VWA | 2.53e-03 | 56 | 316 | 5 | PF00092 | |
| Domain | TSP_3 | 2.76e-03 | 5 | 316 | 2 | PF02412 | |
| Domain | Hexokinase_2 | 2.76e-03 | 5 | 316 | 2 | PF03727 | |
| Domain | RDM_domain_RFPL | 2.76e-03 | 5 | 316 | 2 | IPR022723 | |
| Domain | Thrombospondin_3_rpt | 2.76e-03 | 5 | 316 | 2 | IPR017897 | |
| Domain | TSP_type-3_rpt | 2.76e-03 | 5 | 316 | 2 | IPR028974 | |
| Domain | Hexokinase_C | 2.76e-03 | 5 | 316 | 2 | IPR022673 | |
| Domain | Hexokinase_N | 2.76e-03 | 5 | 316 | 2 | IPR022672 | |
| Domain | Hexokinase_1 | 2.76e-03 | 5 | 316 | 2 | PF00349 | |
| Domain | RDM | 2.76e-03 | 5 | 316 | 2 | PF11002 | |
| Domain | - | 2.76e-03 | 5 | 316 | 2 | 4.10.1080.10 | |
| Domain | Thrombospondin_C | 2.76e-03 | 5 | 316 | 2 | IPR008859 | |
| Domain | HEXOKINASE_2 | 2.76e-03 | 5 | 316 | 2 | PS51748 | |
| Domain | Znf_FCS | 2.76e-03 | 5 | 316 | 2 | IPR012313 | |
| Domain | TSP3 | 2.76e-03 | 5 | 316 | 2 | PS51234 | |
| Domain | TSP_CTER | 2.76e-03 | 5 | 316 | 2 | PS51236 | |
| Domain | P-type_TPase_V | 2.76e-03 | 5 | 316 | 2 | IPR006544 | |
| Domain | Hexokinase_BS | 2.76e-03 | 5 | 316 | 2 | IPR019807 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | CLTCL1 VWA8 SIPA1L3 OBSCN JADE1 ACOX3 TBC1D9 PLEKHH3 ITPR2 SNX30 MDN1 INTS11 PDZD8 HES6 GNA12 PLEC HECTD1 DYNC1H1 NDST1 EP400 KALRN MTHFD1L GRID1 LRRK1 ATP13A2 EML3 PHC2 PIM3 RADIL ARHGEF40 IGF1R TMEM203 CELSR2 TRAPPC12 CSPG4 NUP188 PC ESPL1 TJP3 | 1.14e-12 | 1105 | 323 | 39 | 35748872 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | MAP2 OBSCN PHB1 MDN1 ANKRD28 ASCC3 SDCBP ANAPC4 CACNA1C FLT1 NWD1 COL6A6 MTHFD1L IFT81 SPG11 LCP1 TMEM87A IGF1R DNAH12 LGI2 CAPN7 ARID2 VPS35 IK CNOT1 | 1.09e-11 | 497 | 323 | 25 | 36774506 |
| Pubmed | VWA8 LGR4 CHEK1 GPR108 BRWD3 FANCD2 BPTF HMCN2 INTS11 CRNN PEX5 ANKRD28 RARS2 ASCC3 MTO1 ANAPC4 ARAP2 VLDLR OGT EP400 DDX52 HTATIP2 SLC4A1 EDEM3 ARHGEF40 SF3B3 ARID2 ANKRD17 NUP188 CRYBG3 LONRF3 CLSPN UNC80 SEZ6L | 1.62e-09 | 1116 | 323 | 34 | 31753913 | |
| Pubmed | SRP68 UNC45A PHB1 KARS1 MDN1 PDS5A PLEC ASCC3 HECTD1 PLS3 DYNC1H1 CAD ANKFY1 DDX52 NUP98 PPP4R3A SF3B3 NUP155 WDHD1 VPS35 PKN2 NUP188 SNRPA1 CNOT1 STAG2 | 1.98e-09 | 638 | 323 | 25 | 33239621 | |
| Pubmed | VWA8 VPS13C ADGRB3 JADE1 ADGRV1 FEM1C CDK14 KARS1 CPSF2 CARNS1 EP400 SPG11 LRRK1 PPP4R3B SF3B3 NUP155 EFR3B ANKRD17 NUP188 DAAM1 ESPL1 CNOT1 | 6.54e-09 | 529 | 323 | 22 | 14621295 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | VWA8 SRP68 UNC45A FEM1C PHB1 ANKRD28 PLEC ASCC3 HECTD1 ANKFY1 OGT DYNC2H1 MTHFD1L USP29 NUP98 DPP3 KLHL22 TMEM203 NUP155 KCTD10 KLHL15 VPS35 KCTD3 ANKRD17 UGGT2 PKN2 NUP188 SNRPA1 CNOT1 CRBN | 2.46e-08 | 1005 | 323 | 30 | 19615732 |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | CNNM2 CLTCL1 TRPM2 ERBIN PHB1 FANCD2 PTPRE INTS11 ANKRD28 DYNC1H1 ST13P4 CAD PPP4R3A PPP1R7 ANKRD44 PPP4R3B CNNM4 SF3B3 KLHL15 KCTD3 SNRPA1 MAN1B1 | 2.72e-08 | 573 | 323 | 22 | 28330616 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | HK1 MAP2 VWA8 SRP68 PHB1 BPTF KARS1 INTS11 PDS5A GNA12 DHX35 PLEC CPSF2 DYNC1H1 CAD FYTTD1 OGT EP400 KALRN PHC2 SF3B3 UPF2 PABPN1 ARID2 DHRS7 KCTD10 RCL1 KCTD3 IK SNRPA1 CNOT1 | 3.59e-08 | 1082 | 323 | 31 | 38697112 |
| Pubmed | MYH11 RC3H1 SIPA1L3 TBC1D9 RGL1 SMYD4 TRPM3 DSTYK PDS5A HECTD1 DYNC2H1 PPP4R3A CNNM4 RADIL ARID2 DNAH17 LRRCC1 WSCD2 UNC80 TMEM63A | 4.85e-08 | 493 | 323 | 20 | 15368895 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DIS3L2 HK1 PNO1 SRP68 UNC45A ERBIN PHB1 KARS1 MDN1 PLAA INTS11 ANKRD28 PDS5A PLEC ASCC3 DYNC1H1 CAD ANKFY1 EP400 MTHFD1L DDX52 SMTN ARHGEF40 GTF2H4 SF3B3 NUP155 UPF2 PABPN1 MAP4K5 VPS35 RCL1 ANKRD17 PKN2 IK SNRPA1 | 5.60e-08 | 1353 | 323 | 35 | 29467282 |
| Pubmed | HK1 SRP68 BPTF KARS1 MDN1 ANKRD28 PDS5A PLEC ASCC3 HECTD1 DYNC1H1 CAD MTHFD1L DDX52 NUP98 LCP1 NUP155 RCL1 ANKRD17 NUP188 IK CNOT1 STAG2 | 6.25e-08 | 653 | 323 | 23 | 22586326 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | MYH11 PNO1 SRP68 UNC45A PHB1 FANCD2 KARS1 PLAA PDS5A RFT1 ASCC3 HECTD1 DYNC1H1 AMPD2 DYNC2H1 DDX52 NUP98 CNNM4 ARHGEF40 NUP155 DHRS7 VPS35 ANKRD17 UGGT2 NUP188 ESPL1 STAG2 MAN1B1 | 8.03e-08 | 942 | 323 | 28 | 31073040 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | MYH11 ATR UNC45A PLEC MAGEC1 ASCC3 HECTD1 CAD THBS1 ARHGEF40 ANKRD17 CNOT1 | 4.81e-07 | 202 | 323 | 12 | 33005030 |
| Pubmed | CDK17 CDK18 HK1 MAP2 VWA8 UNC45A ERBIN ITPR2 PHB1 HSPA13 MDN1 PDZD8 ANKRD28 ASCC3 PLS3 PMS1 CAD DYNC2H1 MTHFD1L IFT81 SPG11 SF3B3 NUP155 MAP4K5 MACO1 DHRS7 VPS35 RCL1 EFR3B UGGT2 PKN2 CRYBG3 DAAM1 ESPL1 SMCR8 | 5.22e-07 | 1487 | 323 | 35 | 33957083 | |
| Pubmed | SIPA1L3 PNO1 SRP68 DENND2D UNC45A ERBIN PHC3 MDN1 PURB INTS11 PDS5A CPSF2 ASCC3 PLS3 SDCBP CAD FYTTD1 OGT EP400 MTHFD1L DDX52 CREB3L4 PHC2 SLC30A6 GTF2H4 ARID2 MACO1 RCL1 KCTD3 ANKRD17 DECR2 DAAM1 IK STAG2 MAN1B1 | 6.09e-07 | 1497 | 323 | 35 | 31527615 | |
| Pubmed | SIPA1L3 ERBIN ITPR2 FANCD2 KARS1 PTPRE INTS11 PDZD8 ANKRD28 CPSF2 HSD17B3 PMS1 CAD NUP98 HID1 PPP4R3A PPP1R7 PPP4R3B CNNM4 NUP155 MACO1 KLHL15 KCTD3 EFR3B CRYBG3 IK PC CNOT1 | 6.97e-07 | 1049 | 323 | 28 | 27880917 | |
| Pubmed | CDK18 VPS13C CFTR SRP68 ADGRV1 ERBIN ITPR2 PHB1 CPSF2 TRIM46 CACNA1E MTHFD1L THBS1 KCTD3 CTNNA3 DECR2 PC | 7.11e-07 | 430 | 323 | 17 | 32581705 | |
| Pubmed | MYH11 HK1 CLTCL1 COPZ2 MYLK NLRP7 SIPA1L3 ERBIN PHB1 BPTF MDN1 STXBP2 CC2D2A KRT20 GNA12 PLEC CACNA1C CACNA1E DDX52 IFT81 NUP98 HKDC1 SPG11 LCP1 SF3B3 ETHE1 ARHGAP12 CSPG4 VPS35 MYH15 UGGT2 ATP1A4 STAG2 CFAP46 | 7.38e-07 | 1442 | 323 | 34 | 35575683 | |
| Pubmed | 7.94e-07 | 3 | 323 | 3 | 8666668 | ||
| Pubmed | 7.94e-07 | 3 | 323 | 3 | 21995812 | ||
| Pubmed | 7.94e-07 | 3 | 323 | 3 | 27979966 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | UNC45A ERBIN ITPR2 BPTF KARS1 PURB PDS5A CPSF2 OGT EP400 SMARCAL1 YIF1B WDHD1 UPF2 NUP188 | 8.64e-07 | 341 | 323 | 15 | 32971831 |
| Pubmed | SRP68 UNC45A ERBIN PHB1 PDZD8 PDS5A ASCC3 PLS3 DYNC1H1 CAD ATG2B SF3B3 NUP155 MAP4K5 ARHGAP12 EFR3B ANKRD17 PKN2 CRYBG3 SNRPA1 SMCR8 CNOT1 | 1.00e-06 | 708 | 323 | 22 | 39231216 | |
| Pubmed | ATR UNC45A PHB1 FANCD2 BPTF KARS1 MDN1 PDS5A PLEC CPSF2 ST13P4 CAD OGT EP400 ATG7 SMARCAL1 NUP98 POLE4 PPP4R3A PHC2 PPP4R3B SF3B3 NUP155 WDHD1 PABPN1 IK STAG2 | 1.16e-06 | 1014 | 323 | 27 | 32416067 | |
| Pubmed | PRR5L OBSCN LGR4 PABPN1L JADE1 ERBIN PHC3 PLAA PURB PLEC CPSF2 MTO1 AMPD2 FYTTD1 OGT DDX52 DDI2 SMTN WDHD1 ANKRD17 NUP188 EPDR1 IK ESPL1 CNOT1 STAG2 MAN1B1 LRRC71 | 1.32e-06 | 1084 | 323 | 28 | 11544199 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TRAF1 HK1 ATR VPS13C SRP68 UNC45A PHB1 FANCD2 KARS1 MDN1 INTS11 CC2D2A PDS5A PLS3 SDCBP DYNC1H1 CAD ANKFY1 DYNC2H1 MTHFD1L DDX52 NUP98 SF3B3 NUP155 PABPN1 VPS35 RCL1 NUP188 IK PC SNRPA1 CNOT1 STAG2 | 1.60e-06 | 1425 | 323 | 33 | 30948266 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | OMA1 HK1 AUH VWA8 VPS13C CHEK1 CHML ITPR2 PHB1 FANCD2 SPTBN5 MDN1 PURB PEX5 PDZD8 RARS2 DHX35 MTO1 CAD MTHFD1L ATG2B NUP98 SLC30A6 NUP155 UPF2 ARID2 MACO1 DHRS7 ARHGAP12 RCL1 NUP188 CRYBG3 ESPL1 SMCR8 | 1.67e-06 | 1496 | 323 | 34 | 32877691 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | TRAF1 MYLK ATR STK17A CHEK1 CDK14 ACOX3 ITPR2 PLEC SLC25A23 ANAPC4 ANKFY1 EML3 SLC30A6 ARHGEF40 IGF1R GTF2H4 YIF1B MAP4K5 CAPN7 MYH15 PKN2 NUP188 CLSPN ESPL1 | 1.69e-06 | 910 | 323 | 25 | 36736316 |
| Pubmed | MYH11 AUH VWA8 SIPA1L3 TRPM2 SRP68 UNC45A PHC3 KARS1 PURB INTS11 TRPM1 PLEC CPSF2 ASCC3 PLS3 DYNC1H1 RC3H2 FYTTD1 EP400 DDX52 SMARCAL1 PHC2 ARHGEF40 UPF2 PABPN1 RCL1 ANKRD17 DECR2 PC CNOT1 CRBN | 1.97e-06 | 1371 | 323 | 32 | 36244648 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | HK1 MAP2 PNO1 SRP68 UNC45A FANCD2 CDAN1 KARS1 PLAA PURB PEX5 ANKRD28 PLEC HECTD1 PLS3 DYNC1H1 AMPD2 ANKFY1 OGT ATG7 NUP98 DDI2 ARMC9 DPP3 PPP4R3A PPP1R7 PPP4R3B NUP155 WDHD1 VPS35 NUP188 SNRPA1 CNOT1 | 2.50e-06 | 1455 | 323 | 33 | 22863883 |
| Pubmed | MAP2 CHEK1 DDT CPSF2 ASCC3 ANAPC4 EP400 MTHFD1L PHC2 RADIL RCL1 PKN2 PC | 2.68e-06 | 281 | 323 | 13 | 24163370 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | ATR SRP68 CHEK1 UNC45A FANCD2 MDN1 PLEC CPSF2 DYNC1H1 FYTTD1 SF3B3 NUP155 PABPN1 PKP3 PKN2 IK SNRPA1 CNOT1 STAG2 | 2.73e-06 | 582 | 323 | 19 | 20467437 |
| Pubmed | 3.15e-06 | 4 | 323 | 3 | 19828454 | ||
| Pubmed | The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways. | 3.15e-06 | 4 | 323 | 3 | 14988723 | |
| Pubmed | Claspin operates downstream of TopBP1 to direct ATR signaling towards Chk1 activation. | 3.15e-06 | 4 | 323 | 3 | 16880517 | |
| Pubmed | PCTAIRE-1 and PCTAIRE-3, two members of a novel cdc2/CDC28-related protein kinase gene family. | 3.15e-06 | 4 | 323 | 3 | 1437147 | |
| Pubmed | Linking PCNA-dependent replication and ATR by human Claspin. | 3.15e-06 | 4 | 323 | 3 | 17274954 | |
| Pubmed | 3.15e-06 | 4 | 323 | 3 | 26147384 | ||
| Pubmed | 3.15e-06 | 4 | 323 | 3 | 31636267 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | SRP68 BPTF KARS1 MDN1 PDS5A PLEC CPSF2 DYNC1H1 EP400 EML3 WDHD1 ARID2 PKN2 STAG2 | 3.27e-06 | 332 | 323 | 14 | 32786267 |
| Pubmed | Dynamic expression of the TRPM subgroup of ion channels in developing mouse sensory neurons. | 3.41e-06 | 12 | 323 | 4 | 19850157 | |
| Pubmed | 3.41e-06 | 12 | 323 | 4 | 19884882 | ||
| Pubmed | HK1 PNO1 PHB1 MDN1 ASCC3 PLS3 SDCBP DYNC1H1 CAD MTHFD1L NUP98 CNNM4 NUP155 VPS35 NUP188 PC CNOT1 | 3.51e-06 | 484 | 323 | 17 | 31995728 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MAP2 HEBP2 VPS13C SIPA1L3 TRPM2 OBSCN ATP9B ADGRV1 CDK14 ADARB1 ERBIN BRWD3 DDT SNX30 BPTF PTPRE ABCC8 TBC1D14 HECTD1 CACNA1C FYTTD1 OGT ATG7 ANKRD44 CNNM4 IGF1R PKP3 ANKRD17 DAAM1 CNOT1 STAG2 MAN1B1 TMEM63A | 4.07e-06 | 1489 | 323 | 33 | 28611215 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | CDK17 UNC45A CDK14 DDT CDAN1 PI4KB DSTYK TONSL PDS5A RARS2 CPSF2 PLS3 DYNC1H1 OGT MTHFD1L NUP98 LRRK1 EML3 PPP4R3A CRB1 PPP1R7 PPP4R3B CNNM4 RADIL IGF1R SF3B3 VPS35 NUP188 SNRPA1 CNOT1 | 4.11e-06 | 1284 | 323 | 30 | 17353931 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ATR ADARB1 ERBIN TBC1D9 FANCD2 BPTF PHC3 MDN1 PURB PLEC CPSF2 EP400 NUP98 PPP4R3A PHC2 SMTN WDHD1 PKP3 ANKRD17 PKN2 ESPL1 STAG2 | 4.21e-06 | 774 | 323 | 22 | 15302935 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | ITPR2 DHX35 ASCC3 HECTD1 ANAPC4 CAD EP400 NUP98 PPP4R3A PPP4R3B GTF2H4 NUP155 ARID2 ANKRD17 NUP188 ESPL1 | 4.40e-06 | 440 | 323 | 16 | 34244565 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CDK16 CDK17 SIPA1L3 CHEK1 PHB1 PLAA PDS5A DHX35 PLS3 DYNC1H1 ANAPC4 OGT NUP98 EML3 SMTN PPP1R7 EDEM3 THBS1 SF3B3 NUP155 ARID2 KCTD10 NUP188 SNRPA1 ESPL1 CNOT1 STAG2 CRBN | 4.41e-06 | 1155 | 323 | 28 | 20360068 |
| Pubmed | SPATA7 HK1 VPS13C LGR4 SRP68 ERBIN PHB1 PI4KB PEX5 ANKRD28 PDS5A DYNC1H1 ARAP2 EP400 NUP98 PCDHB2 CRB1 SLC30A6 NUP155 CLSPN PC SMCR8 | 4.48e-06 | 777 | 323 | 22 | 35844135 | |
| Pubmed | PDE8A VPS13C CHML ITPR2 SNX30 PI4KB PDZD8 ATG2B SPG11 TMEM87A SLC30A6 NUP155 TRAPPC12 MACO1 DHRS7 VPS35 SMCR8 | 5.99e-06 | 504 | 323 | 17 | 34432599 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MAGEB4 VPS13C OBSCN SRP68 CHML ITGAE ITPR2 KARS1 MDN1 TRPM3 TBC1D14 KRT20 PDS5A ANKRD18A DYNC1H1 SLC26A9 DDI2 PPP1R7 THBS4 NUP188 CNOT1 | 6.59e-06 | 736 | 323 | 21 | 29676528 |
| Pubmed | 6.79e-06 | 14 | 323 | 4 | 9373155 | ||
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | HK1 MAP2 VPS13C OBSCN FEM1C CC2D2A KRT20 PLEC CAD OGT REXO5 EP400 EML3 SMTN THBS1 ANKRD17 NUP188 TMEM63A | 6.80e-06 | 564 | 323 | 18 | 21565611 |
| Pubmed | 7.45e-06 | 107 | 323 | 8 | 11347906 | ||
| Pubmed | 7.83e-06 | 5 | 323 | 3 | 21502314 | ||
| Pubmed | Human claspin is required for replication checkpoint control. | 7.83e-06 | 5 | 323 | 3 | 12766152 | |
| Pubmed | 7.83e-06 | 5 | 323 | 3 | 16951182 | ||
| Pubmed | 7.83e-06 | 5 | 323 | 3 | 18451105 | ||
| Pubmed | ABC gene expression profiles have clinical importance and possibly form a new hallmark of cancer. | 7.83e-06 | 5 | 323 | 3 | 28468577 | |
| Pubmed | CNNM2 HK1 GDF10 PTPRE CHRDL1 PDZD8 MSS51 COL17A1 HKDC1 SLC39A12 UPF2 ARHGAP12 CTNNA3 RASSF4 CFAP46 | 9.41e-06 | 415 | 323 | 15 | 16385451 | |
| Pubmed | UNC45A PHB1 KARS1 HECTD1 DYNC1H1 CAD ANKFY1 MTHFD1L NUP98 DDI2 NUP155 ETHE1 VPS35 ANKRD17 PKN2 NUP188 CNOT1 | 1.27e-05 | 534 | 323 | 17 | 35032548 | |
| Pubmed | HK1 CLTCL1 VWA8 UNC45A ERBIN ITPR2 PHB1 FANCD2 KARS1 MDN1 PURB ANKRD28 PDS5A RARS2 ASCC3 PLS3 DYNC1H1 CAD MTHFD1L SMTN CNNM4 SF3B3 YIF1B NUP155 COMMD2 MACO1 VPS35 NUP188 SNRPA1 CNOT1 STAG2 | 1.43e-05 | 1440 | 323 | 31 | 30833792 | |
| Pubmed | 1.55e-05 | 6 | 323 | 3 | 35679425 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | CNNM2 CHEK1 UNC45A FANCD2 ANKRD28 ASCC3 HECTD1 PLS3 OGT MTHFD1L NUP98 LCP1 PPP4R3A CNNM4 NUP155 PKP3 MACO1 VPS35 KCTD3 ANKRD17 NUP188 SNRPA1 ESPL1 MAN1B1 | 1.67e-05 | 974 | 323 | 24 | 28675297 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | SPATA7 CDK16 CDK17 CDK18 PDE8A SRP68 CHEK1 PHB1 KARS1 PI4KB CCDC154 CRNN ANKRD28 PLEC RFT1 PLS3 DYNC1H1 AMPD2 OGT DYNC2H1 IFT81 ATG2B PPP4R3A PPP1R7 CNNM4 SF3B3 KCTD3 UGGT2 CNOT1 | 1.91e-05 | 1321 | 323 | 29 | 27173435 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | SIPA1L3 PNO1 SRP68 UNC45A ITPR2 PHB1 KARS1 PURB PLEC ASCC3 PLS3 DYNC1H1 CAD COL17A1 DDX52 NUP98 PHC2 THBS1 GTF2H4 SF3B3 NUP155 UPF2 PKP3 KCTD10 RCL1 ANKRD17 IK SNRPA1 | 2.06e-05 | 1257 | 323 | 28 | 36526897 |
| Pubmed | VPS13C SRP68 GPR108 ERBIN ITPR2 BOD1 PEX5 PDZD8 ANKRD28 CPSF2 HECTD1 EP400 SPG11 EDEM3 WDHD1 TRAPPC12 MACO1 UGGT2 CLSPN ESPL1 | 2.07e-05 | 733 | 323 | 20 | 34672954 | |
| Pubmed | 2.15e-05 | 202 | 323 | 10 | 24639526 | ||
| Pubmed | USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. | 2.16e-05 | 90 | 323 | 7 | 35654790 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CDK16 CDK17 CDK18 MAP2 SIPA1L3 CHEK1 UNC45A CDK14 ERBIN MDN1 PI4KB DSTYK PLEC HECTD1 ARAP2 AMPD2 RADIL IGF1R ANKRD17 CRYBG3 PC BECN1 | 2.19e-05 | 861 | 323 | 22 | 36931259 |
| Pubmed | 2.24e-05 | 203 | 323 | 10 | 19953087 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | ATR SQLE LGR4 DDT PHB1 HSPA13 FANCD2 MDN1 PDS5A RFT1 DYNC2H1 MTHFD1L HTATIP2 PCDHA12 SPG11 TMEM87A YIF1B CELSR2 SLC15A4 MACO1 DHRS7 UGGT2 NUP188 PC MAN1B1 | 2.33e-05 | 1061 | 323 | 25 | 33845483 |
| Pubmed | 2.70e-05 | 7 | 323 | 3 | 20029092 | ||
| Pubmed | 2.70e-05 | 7 | 323 | 3 | 20233725 | ||
| Pubmed | Autophagy protects the retina from light-induced degeneration. | 2.70e-05 | 7 | 323 | 3 | 23341467 | |
| Pubmed | VPS13C UNC45A BRWD3 PLS3 IFT81 NUP98 PPP4R3A PPP1R7 PPP4R3B KCTD10 | 2.87e-05 | 209 | 323 | 10 | 26389662 | |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | SRP68 CHEK1 PHB1 FANCD2 KARS1 PLAA HECTD1 PLS3 SDCBP DYNC1H1 CAD ANKFY1 OGT NUP98 NUP155 VPS35 NUP188 | 2.95e-05 | 571 | 323 | 17 | 37167062 |
| Pubmed | CDK17 MYH11 HK1 MAP2 SIPA1L3 SRP68 ERBIN ITPR2 KARS1 PURB PLEC SLC25A23 PLS3 SDCBP DYNC1H1 TRIM46 CAD OGT KALRN SLC4A1 PPP1R7 THBS4 SF3B3 UPF2 MTERF2 KCTD10 VPS35 LRRCC1 PC CNOT1 | 3.22e-05 | 1431 | 323 | 30 | 37142655 | |
| Pubmed | FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells. | 3.24e-05 | 212 | 323 | 10 | 33462405 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | PDE8A HEBP2 VPS13C ADGRV1 DDT STXBP2 CRNN SDCBP DYNC1H1 DPEP1 ANKFY1 REXO5 KALRN DYNC2H1 GRID1 ARMC9 LCP1 CRABP2 SLC4A1 PPP1R7 THBS1 CAPN7 VPS35 TMEM63A | 3.27e-05 | 1016 | 323 | 24 | 19056867 |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | SPATA7 AUH VWA8 MIF4GD SRP68 PHB1 KARS1 PDZD8 RARS2 PLEC CPSF2 MOCS1 AMPD2 ANKFY1 MTHFD1L HKDC1 PPP4R3A SLC30A6 SF3B3 YIF1B NUP155 CELSR2 ETHE1 DHRS7 CSPG4 VPS35 UGGT2 EPDR1 SNRPA1 MAN1B1 | 4.15e-05 | 1451 | 323 | 30 | 30550785 |
| Pubmed | 4.29e-05 | 8 | 323 | 3 | 1639063 | ||
| Pubmed | And-1 coordinates with Claspin for efficient Chk1 activation in response to replication stress. | 4.29e-05 | 8 | 323 | 3 | 26082189 | |
| Pubmed | 4.49e-05 | 177 | 323 | 9 | 26206133 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | CDK16 CDK17 PNO1 SRP68 ERBIN PI4KB TBC1D14 PEX5 DHX35 ANAPC4 BBS10 WDHD1 UPF2 PKP3 ARHGAP12 RCL1 KCTD3 IK CLSPN SNRPA1 ESPL1 BECN1 CNOT1 TJP3 | 4.57e-05 | 1038 | 323 | 24 | 26673895 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | VPS13C SIPA1L3 UNC45A STXBP2 PEX5 ANKRD28 PLEC PLS3 DYNC1H1 MTHFD1L IFT81 LCP1 KLHL22 PPP1R7 CAPN7 COMMD2 MACO1 ARHGAP12 LRRCC1 PC CNOT1 | 5.72e-05 | 853 | 323 | 21 | 28718761 |
| Pubmed | VWA8 UNC45A FANCD2 MDN1 ANKRD28 PDS5A RARS2 MTO1 OGT DYNC2H1 MTHFD1L ATG2B POLE4 PPP4R3B NUP155 VPS35 PC | 6.16e-05 | 606 | 323 | 17 | 36538041 | |
| Pubmed | 6.40e-05 | 9 | 323 | 3 | 16682347 | ||
| Pubmed | 6.40e-05 | 9 | 323 | 3 | 28467410 | ||
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | HK1 SIPA1L3 PNO1 PLEKHH3 ITPR2 KARS1 PLS3 SDCBP LCP1 CRABP2 KLHL22 ARHGEF40 PABPN1 PKP3 MACO1 VPS35 ANKRD17 SNRPA1 CNOT1 | 6.47e-05 | 732 | 323 | 19 | 34732716 |
| Pubmed | SRP68 UNC45A ERBIN BPTF ASCC3 PLS3 DYNC1H1 CAD OGT EP400 ATG2B ARID2 PKN2 IK PC CNOT1 | 6.49e-05 | 549 | 323 | 16 | 38280479 | |
| Pubmed | 6.70e-05 | 24 | 323 | 4 | 34653670 | ||
| Pubmed | HK1 CHEK1 UNC45A PHB1 PI4KB MAP3K15 ANKFY1 ATG7 ATG2B NUP155 TRAPPC12 RASSF4 SMCR8 BECN1 | 6.88e-05 | 437 | 323 | 14 | 20562859 | |
| Pubmed | MYH11 HK1 AUH VWA8 OBSCN PHB1 CFAP54 RARS2 PLEC PLS3 DYNC1H1 LAMA2 | 7.12e-05 | 331 | 323 | 12 | 29199018 | |
| Pubmed | MYBPH HEBP2 OBSCN SRP68 KARS1 ANKRD28 PLEC SDCBP ANKFY1 KALRN LAMA2 PPP1R7 UPF2 LONRF3 STAG2 | 7.44e-05 | 497 | 323 | 15 | 23414517 | |
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | DIS3L2 OBSCN STXBP2 GNA12 PLEC DNAH9 PLS3 DYNC1H1 SF3B3 PABPN1 PC SNRPA1 | 7.54e-05 | 333 | 323 | 12 | 32665550 |
| Pubmed | ATR TBC1D9 ITPR2 PHB1 RARS2 ASCC3 HECTD1 NDST1 EDEM3 NUP155 UGGT2 | 8.17e-05 | 285 | 323 | 11 | 32838362 | |
| Pubmed | SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice. | 8.52e-05 | 150 | 323 | 8 | 30154076 | |
| Pubmed | 8.60e-05 | 2 | 323 | 2 | 34884866 | ||
| Pubmed | Overexpression of myosin is associated with the development of uterine myoma. | 8.60e-05 | 2 | 323 | 2 | 25181625 | |
| Interaction | CD79B interactions | ABCA3 LGR4 FANCD2 PLAA DSTYK SLC25A23 ATP13A2 ZAP70 SLC30A6 CD79A NUP188 MAN1B1 | 4.67e-07 | 122 | 314 | 12 | int:CD79B |
| Interaction | TOP3B interactions | CLTCL1 VWA8 SIPA1L3 OBSCN JADE1 UNC45A ACOX3 TBC1D9 PLEKHH3 ITPR2 PHB1 SNX30 KARS1 MDN1 INTS11 PDZD8 HES6 GNA12 PLEC HECTD1 DYNC1H1 NDST1 RC3H2 CAD EP400 KALRN MTHFD1L GRID1 LRRK1 ATP13A2 EML3 PHC2 PIM3 RADIL ARHGEF40 IGF1R TMEM203 CELSR2 UPF2 TRAPPC12 PABPN1 CSPG4 ANKRD17 NUP188 PC ESPL1 CNOT1 TJP3 | 8.36e-07 | 1470 | 314 | 48 | int:TOP3B |
| Interaction | FBXO22 interactions | MAP2 OBSCN PHB1 MDN1 ANKRD28 ASCC3 SDCBP ANAPC4 CACNA1C FLT1 NWD1 COL6A6 MTHFD1L IFT81 SPG11 LCP1 TMEM87A IGF1R DNAH12 LGI2 CAPN7 ARID2 VPS35 IK CNOT1 | 1.39e-06 | 540 | 314 | 25 | int:FBXO22 |
| Interaction | MDN1 interactions | CFTR PHB1 FANCD2 MDN1 PDS5A HECTD1 DPEP1 FLT1 NTRK1 PHC2 IGF1R BECN1 STAG2 | 1.31e-05 | 196 | 314 | 13 | int:MDN1 |
| Interaction | HAX1 interactions | OMA1 HK1 MAP2 RC3H1 CFTR CHEK1 ITPR2 PHB1 FANCD2 MTO1 RC3H2 CAD NTRK1 ATG2B IGF1R NUP188 CRYBG3 ESPL1 BECN1 | 2.12e-05 | 404 | 314 | 19 | int:HAX1 |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 1.81e-04 | 25 | 209 | 4 | 504 | |
| GeneFamily | Cyclin dependent kinases | 2.12e-04 | 26 | 209 | 4 | 496 | |
| GeneFamily | EF-hand domain containing | TBC1D9 CRNN SLC25A23 PLS3 CACNA1E CAPS RCVRN SCGN LCP1 EFCC1 | 2.40e-04 | 219 | 209 | 10 | 863 |
| GeneFamily | Ankyrin repeat domain containing | FEM1C TONSL ANKRD28 ANKRD18A HECTD1 ARAP2 ANKFY1 SLF1 ANKRD44 ANKRD17 | 5.29e-04 | 242 | 209 | 10 | 403 |
| GeneFamily | Autophagy related | 5.46e-04 | 33 | 209 | 4 | 1022 | |
| GeneFamily | Dyneins, axonemal | 9.19e-04 | 17 | 209 | 3 | 536 | |
| GeneFamily | Parkinson disease associated genes|ATPase orphan transporters | 1.30e-03 | 5 | 209 | 2 | 1213 | |
| GeneFamily | Short chain dehydrogenase/reductase superfamily | 1.87e-03 | 76 | 209 | 5 | 743 | |
| GeneFamily | Protein phosphatase 6 regulatory subunits | 1.93e-03 | 6 | 209 | 2 | 699 | |
| GeneFamily | NLR family | 2.90e-03 | 25 | 209 | 3 | 666 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 2.90e-03 | 25 | 209 | 3 | 994 | |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_DN | CDK17 CNNM2 PRR5L FEM1C TLR8 ARAP2 PMS1 TSGA10 BBS10 IGF1R WDHD1 TMEM87B CRYBG3 ESPL1 TJP3 | 3.12e-08 | 200 | 323 | 15 | M8048 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | CDK17 TRAF1 ATR STK17A VPS13C DENND1C DENND2D JADE1 ITGAE ADARB1 ERBIN ITPR2 BPTF PHC3 PTPRE DSTYK ANKRD28 PRMT2 PDS5A ASCC3 FMNL1 DYNC1H1 ARAP2 FYTTD1 OGT SLF1 EP400 NUP98 SPG11 LCP1 EML3 ZAP70 PPP4R3A ANKRD44 PPP4R3B SF3B3 ARID2 DHRS7 IK CNOT1 STAG2 HECA CRBN | 2.03e-07 | 1492 | 323 | 43 | M40023 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CDK17 PDE8A ATR AUH ADARB1 BPTF RGL1 MGAT5 MDN1 ANKRD28 PDS5A ASCC3 ARAP2 PMS1 VLDLR OGT NUP98 SPG11 TMEM87A IGF1R WDHD1 UPF2 MAP4K5 ARHGAP12 ANKRD17 PKN2 CRYBG3 DAAM1 STAG2 | 1.01e-06 | 856 | 323 | 29 | M4500 |
| Coexpression | GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP | CDK17 PDE8A CHML BRWD3 PLEKHH3 AMPD2 EDEM3 DHRS7 KCTD3 PKN2 CRYBG3 RASSF4 | 7.75e-06 | 200 | 323 | 12 | M8500 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL | CDK18 COPZ2 MIF4GD CHEK1 JADE1 SMYD4 PTPRE PI4KB TONSL ANKRD28 NR1H2 KCNMB4 DSCC1 PLTP NDST1 REXO5 SLF1 HTATIP2 OGFOD2 LAMA2 SLC30A6 THBS1 GTF2H4 WDHD1 CTNNA3 LRRCC1 KIAA1755 CRYBG3 CLSPN PC ESPL1 | 7.75e-06 | 1054 | 323 | 31 | M45798 |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | PDE8A ATR SQLE MGAT5 PI4KB PRMT2 PLEC PLTP CAD EP400 NUP98 CELSR2 TRAPPC12 TMEM63A | 9.51e-06 | 276 | 323 | 14 | M3063 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | CDK17 PDE8A ATR AUH ADARB1 BPTF MGAT5 MDN1 PDS5A ASCC3 PMS1 OGT NUP98 UPF2 MAP4K5 ARHGAP12 ANKRD17 PKN2 | 2.23e-05 | 466 | 323 | 18 | M13522 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | ATR STK17A CHEK1 CHML HSPA13 RARS2 PLEC CPSF2 ASCC3 HECTD1 PMS1 RC3H2 FYTTD1 DYNC2H1 MTHFD1L DDX52 PPP4R3B WDHD1 MAP4K5 COMMD2 VPS35 UGGT2 CNOT1 | 3.53e-05 | 721 | 323 | 23 | M10237 |
| Coexpression | GSE40273_XBP1_KO_VS_WT_TREG_DN | TRAF1 ABCA3 ITGAE ITPR2 CHRDL1 KCNMB4 PLEC NDST1 DDI2 LRRK1 RASSF4 | 3.95e-05 | 199 | 323 | 11 | M9124 |
| ToppCell | Ciliated_cells-B|World / lung cells shred on cell class, cell subclass, sample id | MRLN FABP6 CFAP54 CRNN TTLL10 DNAH9 NWD1 CAPS DNAH12 CCDC181 LRRC71 CFAP46 CFAP157 LRRC74B | 1.26e-10 | 190 | 322 | 14 | 7031fbedc13be1a00f6333ad6d51849c3739c2e6 |
| ToppCell | Epithelial_cells-Ciliated_cells-B|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | MRLN FABP6 CFAP54 CRNN TTLL10 DNAH9 NWD1 CAPS DNAH12 CCDC181 LRRC71 CFAP46 CFAP157 LRRC74B | 1.26e-10 | 190 | 322 | 14 | 426a4806f6e39d4d57c6746609d30bb3ca62df7d |
| ToppCell | Ciliated_cells-B-HP_01|World / lung cells shred on cell class, cell subclass, sample id | MRLN FABP6 CFAP54 CRNN TTLL10 DNAH9 NWD1 CAPS DNAH12 CCDC181 LRRC71 CFAP46 CFAP157 | 1.19e-09 | 187 | 322 | 13 | bc1f33f332ac939c2425f510173430ca2ba0c3ee |
| ToppCell | Ciliated_cells-B-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | MRLN FABP6 CFAP54 CRNN TTLL10 DNAH9 DYNC2H1 CAPS DNAH12 CCDC181 LRRC71 CFAP46 CFAP157 | 1.19e-09 | 187 | 322 | 13 | 2b4262c2e7c7830a976be168cee6eeb738d4feda |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-F_(Ciliated)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | MRLN FABP6 CFAP54 CRNN TTLL10 DNAH9 DYNC2H1 CAPS DNAH12 CCDC181 LRRC71 CFAP46 CFAP157 | 1.27e-09 | 188 | 322 | 13 | 5ba5cbb403518026e9040379fb5d99339ea977d8 |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | MRLN FABP6 CFAP54 ANKRD18A TTLL10 DNAH9 DYNC2H1 CAPS TSGA10 DNAH12 CCDC181 CFAP46 CFAP157 | 2.71e-09 | 200 | 322 | 13 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CFAP54 ANKRD18A TTLL10 DNAH9 NWD1 DYNC2H1 CAPS DNAH12 LRRC71 CFAP46 CFAP157 LRRC74B | 4.11e-09 | 169 | 322 | 12 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f |
| ToppCell | Ciliated_cells-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | CYP2F1 MRLN FABP6 CRNN TTLL10 DNAH9 NWD1 CAPS DNAH12 CCDC181 CFAP46 CFAP157 | 7.86e-09 | 179 | 322 | 12 | 0e6c22de2e3fb0ff23b3301863cf4011c5c59dff |
| ToppCell | Ciliated_cells-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | MRLN FABP6 CFAP54 CRNN TTLL10 DNAH9 NWD1 DNAH12 LRRC71 CFAP46 CFAP157 LRRC74B | 1.14e-08 | 185 | 322 | 12 | 4fc7113d3dadc716ec5a8e62b58543cc00ce5b16 |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | MRLN CFAP54 CRNN TTLL10 DNAH9 NWD1 DYNC2H1 CAPS DNAH12 CFAP46 CFAP157 LRRC74B | 1.14e-08 | 185 | 322 | 12 | f012c243343e1d1956db19b34d062e9b13de2b2a |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | MRLN CFAP54 CC2D2A ANKRD18A TTLL10 DNAH9 NWD1 DYNC2H1 DNAH12 CCDC181 CFAP46 CFAP157 | 1.21e-08 | 186 | 322 | 12 | 76033438426d8f9c72cd6691a7baf92104c9f03d |
| ToppCell | (7)_Epithelial-F_(Ciliated)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | MRLN FABP6 CRNN TTLL10 DNAH9 NWD1 CAPS DNAH12 CCDC181 LRRC71 CFAP46 CFAP157 | 1.36e-08 | 188 | 322 | 12 | 9a8b9f745eed9f129b6c582f48fbbaaacbebb4b3 |
| ToppCell | Ciliated|World / shred by cell class for parenchyma | MRLN FABP6 CFAP54 CRNN TTLL10 DNAH9 CAPS DNAH12 CCDC181 LRRC71 CFAP46 CFAP157 | 1.45e-08 | 189 | 322 | 12 | 711181ca3b9102fb155168b646b0a9b09ff215b2 |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)|343B / Donor, Lineage, Cell class and subclass (all cells) | MRLN FABP6 CFAP54 TTLL10 DNAH9 DYNC2H1 CAPS DNAH12 CCDC181 LRRC71 CFAP46 CFAP157 | 1.53e-08 | 190 | 322 | 12 | 169e600e95878000acf5d11f813f9028c7249646 |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)-|343B / Donor, Lineage, Cell class and subclass (all cells) | MRLN FABP6 CFAP54 TTLL10 DNAH9 DYNC2H1 CAPS DNAH12 CCDC181 LRRC71 CFAP46 CFAP157 | 1.53e-08 | 190 | 322 | 12 | 0cc36117c793d83cf4a1f66f47758a07d6712bd3 |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | MRLN FABP6 CFAP54 TTLL10 DNAH9 NWD1 CAPS DNAH12 BCO2 CCDC181 CFAP46 CFAP157 | 1.53e-08 | 190 | 322 | 12 | a90a38fccdbf75a286b4d258fc54920c02b282f7 |
| ToppCell | multiciliated|World / shred by cell class for turbinate | MRLN FABP6 CRNN TTLL10 DNAH9 NWD1 DYNC2H1 CAPS DNAH12 LRRC71 CFAP46 CFAP157 | 1.72e-08 | 192 | 322 | 12 | 0f89ea0deb651ca11531c51ee94e0233608d22ea |
| ToppCell | ASK452-Epithelial-Ciliated|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | FABP6 CC2D2A DNAH9 NWD1 IFT81 CAPS DNAH12 CCDC181 IK LRRC71 CFAP46 CFAP157 | 1.93e-08 | 194 | 322 | 12 | 5aeb44657ab6f61b1abf98af28d3397d8e44c1aa |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CFAP54 ANKRD18A TTLL10 DNAH9 DYNC2H1 IFT81 CAPS TSGA10 DNAH12 CFAP46 CFAP157 LRRC74B | 1.93e-08 | 194 | 322 | 12 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 |
| ToppCell | BL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | FABP6 CC2D2A TTLL10 DNAH9 NWD1 DYNC2H1 CAPS DNAH12 CCDC181 LRRC71 CFAP46 CFAP157 | 2.05e-08 | 195 | 322 | 12 | 07a6bcef6af93ed87df455dee624037cb75e011a |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | MRLN CFAP54 CC2D2A TTLL10 DNAH9 NWD1 DYNC2H1 IFT81 DNAH12 LRRC71 CFAP46 CFAP157 | 2.05e-08 | 195 | 322 | 12 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYH11 MYO7B CFTR COL6A5 ADGRV1 DNAH9 LAMA2 ATP13A5 CRB1 MYH15 UNC80 | 2.56e-08 | 160 | 322 | 11 | c381ec6be8cf887861cc18f831a20db42f953fe1 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYH11 MYO7B CFTR COL6A5 ADGRV1 DNAH9 LAMA2 ATP13A5 CRB1 MYH15 UNC80 | 2.56e-08 | 160 | 322 | 11 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | FABP6 CFAP54 TTLL10 DNAH9 NWD1 CAPS DNAH12 CCDC181 LRRC71 CFAP46 CFAP157 LRRC74B | 2.71e-08 | 200 | 322 | 12 | 918b576fd9491d23c2bb9d663fa5fb3505cb1c7e |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | FABP6 CFAP54 TTLL10 DNAH9 NWD1 CAPS DNAH12 CCDC181 LRRC71 CFAP46 CFAP157 LRRC74B | 2.71e-08 | 200 | 322 | 12 | ddd39b754bfaa98249d497dfb7e97ec58617a11a |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Ciliated|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | FABP6 CFAP54 TTLL10 DNAH9 NWD1 CAPS DNAH12 CCDC181 LRRC71 CFAP46 CFAP157 LRRC74B | 2.71e-08 | 200 | 322 | 12 | a521cf837cadf280505ff9d7e641a205af7d6513 |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYH11 MYLK MAP2 PABPN1L CARNS1 SLC25A23 CACNA1C KALRN TG CELSR2 CTNNA3 | 5.08e-08 | 171 | 322 | 11 | b54d9d6b03c9c6f28a71cf2ed2bfa9a335bba949 |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYH11 MYLK MAP2 PABPN1L CARNS1 SLC25A23 CACNA1C KALRN TG CELSR2 CTNNA3 | 5.08e-08 | 171 | 322 | 11 | 9d825a2e799421af4f2cf4f4dc8e239b5d00476d |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CYP2F1 CFAP54 TTLL10 DNAH9 NWD1 DYNC2H1 CAPS DNAH12 CFAP46 CFAP157 LRRC74B | 6.82e-08 | 176 | 322 | 11 | dee780cfa85234a7cd7bf440b66b84cec959893e |
| ToppCell | Ciliated_cells-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | MRLN FABP6 CFAP54 CRNN TTLL10 NWD1 CAPS DNAH12 CCDC181 CFAP46 CFAP157 | 7.23e-08 | 177 | 322 | 11 | c38138fb5ad9766c2d240811210c854338cd612e |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | FABP6 CFAP54 TTLL10 DNAH9 NWD1 CAPS DNAH12 LRRC71 CFAP46 CFAP157 LRRC74B | 9.60e-08 | 182 | 322 | 11 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 |
| ToppCell | Ciliated_cells-B-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | FABP6 CRNN TTLL10 DNAH9 CAPS DNAH12 CCDC181 LRRC71 CFAP46 CFAP157 LRRC74B | 9.60e-08 | 182 | 322 | 11 | e44c4810dc7d51a76b86d7623f8e4c4d8b4bf2fc |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYO7B CFTR OBSCN ADGRV1 TRPM3 DNAH9 KALRN GRID1 MYH15 ATP1A4 UNC80 | 1.07e-07 | 184 | 322 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYO7B CFTR OBSCN ADGRV1 TRPM3 DNAH9 KALRN GRID1 MYH15 ATP1A4 UNC80 | 1.07e-07 | 184 | 322 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYO7B CFTR OBSCN ADGRV1 TRPM3 DNAH9 KALRN GRID1 MYH15 ATP1A4 UNC80 | 1.07e-07 | 184 | 322 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | Ciliated_cells-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | CYP2A7 CYP2F1 MRLN CRNN TTLL10 DNAH9 NWD1 CAPS DNAH12 CFAP157 LRRC74B | 1.07e-07 | 184 | 322 | 11 | 07c5a9633ccdcd18771e3230d6198a55c400afa6 |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | MRLN CFAP54 CC2D2A TTLL10 DNAH9 NWD1 DYNC2H1 DNAH12 LRRC71 CFAP46 CFAP157 | 1.13e-07 | 185 | 322 | 11 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 |
| ToppCell | Ciliated_cells-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | FABP6 CFAP54 TTLL10 DNAH9 NWD1 CAPS DNAH12 CCDC181 LRRC71 CFAP46 CFAP157 | 1.20e-07 | 186 | 322 | 11 | f72267d533fd0c5280d9741ceee3dd116300a7e4 |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | CNNM2 MYH11 MYLK MAP2 ADARB1 HMCN2 PLS3 CACNA1C KALRN MTHFD1L SMTN | 1.33e-07 | 188 | 322 | 11 | 34e1b074a3995aa46ab194eb45115d76d1a5514d |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | CFAP54 DNAH9 PLTP SLF1 DYNC2H1 IFT81 DNAH12 CCDC181 LRRC71 CFAP46 LRRC74B | 1.33e-07 | 188 | 322 | 11 | 8f30535a32968a81a304315a49c0d90a77d36948 |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | MRLN FABP6 CFAP54 TTLL10 DNAH9 NWD1 DNAH12 CCDC181 LRRC71 CFAP46 CFAP157 | 1.41e-07 | 189 | 322 | 11 | dc440015949a768188c67661b6be63b1ead1a0f0 |
| ToppCell | Ciliated_cells-A|World / lung cells shred on cell class, cell subclass, sample id | CYP2F1 FABP6 CRNN TTLL10 DNAH9 NWD1 CAPS DNAH12 CCDC181 CFAP46 CFAP157 | 1.48e-07 | 190 | 322 | 11 | cd87731aaa7d252424f79cfce9f7931457f17bdf |
| ToppCell | Ciliated_cells-A-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | MRLN FABP6 CFAP54 CRNN TTLL10 DNAH9 NWD1 DNAH12 CFAP46 CFAP157 | 1.58e-07 | 151 | 322 | 10 | 9d03ce73af15ef40c592d19b36aff46bebc14c40 |
| ToppCell | ASK452-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | FABP6 CC2D2A DNAH9 IFT81 CAPS DNAH12 CCDC181 IK LRRC71 CFAP46 CFAP157 | 1.74e-07 | 193 | 322 | 11 | c0d10075862ac878aa05fc49c8b73e470783bf16 |
| ToppCell | Bronchial_Brush|World / Tissue, Lineage and Cell class of Lung Cells from 10X | FABP6 CFAP54 TTLL10 DNAH9 NWD1 DYNC2H1 CAPS DNAH12 CCDC181 CFAP46 CFAP157 | 1.74e-07 | 193 | 322 | 11 | 3e693ac4c92576e3f2c9efdd3f1d96d3d336e260 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CFAP54 CC2D2A TTLL10 DNAH9 NWD1 DYNC2H1 CAPS DNAH12 CCDC181 LRRC71 CFAP46 | 1.74e-07 | 193 | 322 | 11 | e1b76102f812c433195d1e8811fdd3293a7bc22e |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | ATR ADGRV1 CHML BPTF PDS5A HECTD1 DYNC1H1 DDI2 CRYBG3 SMCR8 STAG2 | 1.74e-07 | 193 | 322 | 11 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | FABP6 CFAP54 CC2D2A TTLL10 DNAH9 NWD1 DYNC2H1 DNAH12 CCDC181 CFAP46 CFAP157 | 1.83e-07 | 194 | 322 | 11 | b4ce60c06568123008b1081d644733cb91c28f51 |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | MRLN CFAP54 CC2D2A TTLL10 DNAH9 NWD1 DYNC2H1 DNAH12 LRRC71 CFAP46 CFAP157 | 1.83e-07 | 194 | 322 | 11 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | FABP6 CFAP54 TTLL10 DNAH9 NWD1 DYNC2H1 CAPS DNAH12 CCDC181 CFAP46 CFAP157 | 1.83e-07 | 194 | 322 | 11 | a46238514bca920c3e3713d23c18ba24a09e2a29 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | FABP6 CFAP54 TTLL10 DNAH9 NWD1 DYNC2H1 CAPS DNAH12 CCDC181 CFAP46 CFAP157 | 1.93e-07 | 195 | 322 | 11 | 93b1559382a12cfb158aa5fac7386e38b4f87989 |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | FABP6 CC2D2A TTLL10 DNAH9 NWD1 DYNC2H1 CAPS DNAH12 CCDC181 CFAP46 CFAP157 | 1.93e-07 | 195 | 322 | 11 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | MRLN CFAP54 CC2D2A TTLL10 DNAH9 PLTP NWD1 DYNC2H1 DNAH12 CFAP46 CFAP157 | 1.93e-07 | 195 | 322 | 11 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | MRLN FABP6 CFAP54 TTLL10 DNAH9 NWD1 CAPS DNAH12 CCDC181 IK CFAP46 | 1.93e-07 | 195 | 322 | 11 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | FABP6 CFAP54 TTLL10 DNAH9 NWD1 DYNC2H1 CAPS DNAH12 CCDC181 CFAP46 CFAP157 | 1.93e-07 | 195 | 322 | 11 | 0e763f36786515698b593e5c93f6a56619c1242d |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | FABP6 CFAP54 TTLL10 DNAH9 NWD1 DYNC2H1 CAPS DNAH12 CCDC181 CFAP46 CFAP157 | 1.93e-07 | 195 | 322 | 11 | 581b04220587e1d5198b1abd6965965ace7803e7 |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | MRLN FABP6 CFAP54 TTLL10 DNAH9 NWD1 CAPS DNAH12 CCDC181 IK CFAP46 | 1.93e-07 | 195 | 322 | 11 | 129ad5f4253ecb1a8477cc38773e6e91ea9570b0 |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | MRLN FABP6 CFAP54 TTLL10 DNAH9 NWD1 CAPS DNAH12 CCDC181 IK CFAP46 | 1.93e-07 | 195 | 322 | 11 | 3e70ee987d66d450062d5df3d7c733ccc7344470 |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | CFAP54 CC2D2A TTLL10 DNAH9 NWD1 DYNC2H1 IFT81 DNAH12 CCDC181 CFAP46 CFAP157 | 2.03e-07 | 196 | 322 | 11 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | CFAP54 CC2D2A TTLL10 DNAH9 NWD1 DYNC2H1 IFT81 TSGA10 DNAH12 CFAP46 CFAP157 | 2.25e-07 | 198 | 322 | 11 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | FABP6 CFAP54 TTLL10 DNAH9 NWD1 CAPS DNAH12 LRRC71 CFAP46 CFAP157 LRRC74B | 2.36e-07 | 199 | 322 | 11 | 542ec45c931b40738df1f3777b00c83be33a514a |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | FABP6 CFAP54 TTLL10 DNAH9 NWD1 CAPS DNAH12 LRRC71 CFAP46 CFAP157 LRRC74B | 2.36e-07 | 199 | 322 | 11 | 2498237b9e895ca4826a3378d9d40989968df72b |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | FABP6 CFAP54 TTLL10 DNAH9 NWD1 CAPS DNAH12 LRRC71 CFAP46 CFAP157 LRRC74B | 2.49e-07 | 200 | 322 | 11 | 926a7ea94b5908aebf103893ea83ce9d25285b65 |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | FABP6 CFAP54 TTLL10 DNAH9 NWD1 CAPS DNAH12 LRRC71 CFAP46 CFAP157 LRRC74B | 2.49e-07 | 200 | 322 | 11 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | MRLN FABP6 TTLL10 DNAH9 NWD1 DYNC2H1 DNAH12 CCDC181 LRRC71 CFAP46 CFAP157 | 2.49e-07 | 200 | 322 | 11 | 8441e289377215a6877640946fe3f6de1f456502 |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | MRLN FABP6 TTLL10 DNAH9 NWD1 CAPS DNAH12 CCDC181 LRRC71 CFAP46 CFAP157 | 2.49e-07 | 200 | 322 | 11 | 5abd6d81e1cc354484ae693fcd708d78926e75b5 |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | MRLN FABP6 TTLL10 DNAH9 NWD1 DYNC2H1 DNAH12 CCDC181 LRRC71 CFAP46 CFAP157 | 2.49e-07 | 200 | 322 | 11 | 7cb3e3bd9e851ccb096e0a3471819471d85ebace |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | MRLN FABP6 TTLL10 DNAH9 NWD1 CAPS DNAH12 CCDC181 LRRC71 CFAP46 CFAP157 | 2.49e-07 | 200 | 322 | 11 | 9c9d2b0276c7b0709c2eeeb0673a2f58106fb14e |
| ToppCell | Tuft-tuft-4|World / Class top | MAP2 ITPR2 MDN1 DHX35 KCNMB4 SH2D7 KALRN EDEM3 SLC15A4 ETHE1 | 5.87e-07 | 174 | 322 | 10 | d6f306ebf66061bf9e9742000bfedce12d277452 |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | MYH11 MAP2 ZUP1 ABCC8 SH2D7 CACNA1C HID1 ARHGAP12 SEZ6L CFAP157 | 6.86e-07 | 177 | 322 | 10 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | FABP6 CFAP54 TTLL10 DNAH9 NWD1 DNAH12 CCDC181 CFAP46 CFAP157 LRRC74B | 7.23e-07 | 178 | 322 | 10 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | CYP2F1 DIPK1B LGR4 JADE1 FEM1C ZUP1 SMYD4 DSTYK KLHL22 CNOT1 | 7.23e-07 | 178 | 322 | 10 | c87945146b2734141f07b39d268e0d8086ee0364 |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)-|368C / Donor, Lineage, Cell class and subclass (all cells) | MRLN FABP6 TTLL10 DNAH9 NWD1 CAPS DNAH12 CCDC181 LRRC71 CFAP157 | 8.42e-07 | 181 | 322 | 10 | 5a4574f1bfd0b4ca78da7effda43420857e17296 |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)|368C / Donor, Lineage, Cell class and subclass (all cells) | MRLN FABP6 TTLL10 DNAH9 NWD1 CAPS DNAH12 CCDC181 LRRC71 CFAP157 | 8.42e-07 | 181 | 322 | 10 | a4e891603645f694687e68e585744ddc1a3c8697 |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | FABP6 CFAP54 DNAH9 NWD1 DYNC2H1 CAPS DNAH12 CCDC181 CFAP46 CFAP157 | 8.85e-07 | 182 | 322 | 10 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Deuterosomal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | HES6 TTLL10 DNAH9 TSGA10 DNAH12 DNAH17 CCDC181 LRRC71 CFAP46 CFAP157 | 8.85e-07 | 182 | 322 | 10 | 000eca5baa6eb2335a1e6d76a13fff5382b0e150 |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D175|Adult / Lineage, Cell type, age group and donor | TRPM2 SPTBN5 RGL1 MGAT5 TBC1D14 PLTP THBS1 SLC39A12 LGI2 RASSF4 | 1.03e-06 | 185 | 322 | 10 | ab5704b96f1d368911308797d10c7c52766ab134 |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | MRLN CFAP54 CC2D2A TTLL10 DNAH9 NWD1 DNAH12 LRRC71 CFAP46 CFAP157 | 1.08e-06 | 186 | 322 | 10 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | FABP6 CFAP54 TTLL10 DNAH9 NWD1 DNAH12 LRRC71 CFAP46 CFAP157 LRRC74B | 1.13e-06 | 187 | 322 | 10 | 9e10ed56090d82589bc457788282f664b70ace4b |
| ToppCell | 21-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class | MRLN CC2D2A TTLL10 DNAH9 NWD1 DNAH12 CCDC181 LRRC71 CFAP46 CFAP157 | 1.13e-06 | 187 | 322 | 10 | 1a2178a195d078d1963947b327c6d0d4f2f48341 |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | MRLN FABP6 DNAH9 DYNC2H1 CAPS DNAH12 BCO2 CCDC181 LRRC71 CFAP157 | 1.19e-06 | 188 | 322 | 10 | da59b5c0a4b11690a39a964c1a0a83e66aa0972b |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | FABP6 CFAP54 TTLL10 DNAH9 NWD1 DNAH12 LRRC71 CFAP46 CFAP157 LRRC74B | 1.19e-06 | 188 | 322 | 10 | 34b11f72ca73153d02edcd09b38983ad1a504659 |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | FABP6 CFAP54 TTLL10 DNAH9 NWD1 DNAH12 LRRC71 CFAP46 CFAP157 LRRC74B | 1.19e-06 | 188 | 322 | 10 | 61a459f3fe57e5728efc72637ff2edc2d343492b |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | MRLN FABP6 DNAH9 DYNC2H1 CAPS DNAH12 BCO2 CCDC181 LRRC71 CFAP157 | 1.19e-06 | 188 | 322 | 10 | 82c006f43c93f4a867953a446864f02b44536a23 |
| ToppCell | Ciliated_cells-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | FABP6 CRNN TTLL10 DNAH9 NWD1 CAPS DNAH12 CCDC181 CFAP46 CFAP157 | 1.19e-06 | 188 | 322 | 10 | 606907c865bd2f11bb6474932716550f7723d858 |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | FABP6 CFAP54 TTLL10 DNAH9 NWD1 CAPS DNAH12 CFAP46 CFAP157 LRRC74B | 1.19e-06 | 188 | 322 | 10 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | FABP6 CFAP54 TTLL10 DNAH9 CAPS DNAH12 LRRC71 CFAP46 CFAP157 LRRC74B | 1.25e-06 | 189 | 322 | 10 | a2da5debd10f27b1280b40141ef0bfef007cc72c |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | FABP6 CFAP54 TTLL10 DNAH9 NWD1 DNAH12 LRRC71 CFAP46 CFAP157 LRRC74B | 1.25e-06 | 189 | 322 | 10 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | FABP6 CFAP54 TTLL10 DNAH9 NWD1 CAPS DNAH12 LRRC71 CFAP46 CFAP157 | 1.25e-06 | 189 | 322 | 10 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d |
| ToppCell | Epithelial-D_(Ciliated)|World / shred on cell class and cell subclass (v4) | CFAP54 DNAH9 IFT81 DNAH12 CCDC181 LRRC71 CFAP46 CFAP157 LRRC74B TJP3 | 1.25e-06 | 189 | 322 | 10 | 0bf560b595c7a8450a46bc821b742b67965bd9f9 |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.25e-06 | 189 | 322 | 10 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | FABP6 CFAP54 TTLL10 DNAH9 NWD1 DNAH12 LRRC71 CFAP46 CFAP157 LRRC74B | 1.25e-06 | 189 | 322 | 10 | b679920f0993e917dd86da082113bfbd85ea1ca5 |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | MRLN CFAP54 CC2D2A TTLL10 DNAH9 DYNC2H1 DNAH12 CCDC181 CFAP46 CFAP157 | 1.31e-06 | 190 | 322 | 10 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 |
| ToppCell | Epithelial_cells-Ciliated_cells-A|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | CYP2F1 CRNN TTLL10 DNAH9 NWD1 CAPS DNAH12 CCDC181 CFAP46 CFAP157 | 1.31e-06 | 190 | 322 | 10 | 549d813a8f23b175875e53347928941f143e236c |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | MRLN CFAP54 CC2D2A TTLL10 DNAH9 DYNC2H1 DNAH12 CCDC181 CFAP46 CFAP157 | 1.31e-06 | 190 | 322 | 10 | 833481ace2800354712e2ce709d5cdfd0aed3d42 |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | FABP6 TTLL10 DNAH9 NWD1 DNAH12 CCDC181 LRRC71 CFAP46 CFAP157 LRRC74B | 1.37e-06 | 191 | 322 | 10 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | FABP6 TTLL10 DNAH9 NWD1 DNAH12 CCDC181 LRRC71 CFAP46 CFAP157 LRRC74B | 1.37e-06 | 191 | 322 | 10 | 995e76bbf07674d95b8ef09e078cf6410af27a09 |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | FABP6 TTLL10 DNAH9 NWD1 DNAH12 CCDC181 LRRC71 CFAP46 CFAP157 LRRC74B | 1.37e-06 | 191 | 322 | 10 | a37f20172b85566b9039254a89680e37fd503fd5 |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)|356C / Donor, Lineage, Cell class and subclass (all cells) | MRLN FABP6 TTLL10 DNAH9 CAPS DNAH12 CCDC181 LRRC71 CFAP46 CFAP157 | 1.37e-06 | 191 | 322 | 10 | e314dd8f1a841cab847ae3703bedfe1bc623ac61 |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | FABP6 TTLL10 DNAH9 NWD1 DNAH12 CCDC181 LRRC71 CFAP46 CFAP157 LRRC74B | 1.37e-06 | 191 | 322 | 10 | 2a8e6d560907e71e9f6e190ca0667da804e25641 |
| Disease | triacylglycerol 52:2 measurement | 2.37e-05 | 55 | 309 | 6 | EFO_0010414 | |
| Disease | Lewy Body Disease | 7.43e-05 | 22 | 309 | 4 | C0752347 | |
| Disease | Global developmental delay | 8.34e-05 | 133 | 309 | 8 | C0557874 | |
| Disease | creatinine measurement | SPATA7 CDK18 SIPA1L3 OBSCN ATP9B ADGRV1 BRWD3 PLEC ASCC3 TRIM46 DENND5B DPEP1 LAMA2 ARMC9 LCP1 FAM135B PHC2 EDEM3 IGF1R CELSR2 MAP4K5 CSPG4 KIAA1755 UNC80 | 1.46e-04 | 995 | 309 | 24 | EFO_0004518 |
| Disease | Ciliopathies | 1.64e-04 | 110 | 309 | 7 | C4277690 | |
| Disease | red blood cell density measurement | PRR5L HK1 ATR ADGRV1 PHB1 SNX30 TRPM3 CC2D2A PLEC PLTP CACNA1C VLDLR EP400 KALRN PPP4R3A PHC2 TG ARHGEF40 MAP4K5 ARID2 RCL1 PKN2 | 1.68e-04 | 880 | 309 | 22 | EFO_0007978 |
| Disease | glucose tolerance test | 1.71e-04 | 27 | 309 | 4 | EFO_0004307 | |
| Disease | lissencephaly (implicated_via_orthology) | 1.71e-04 | 27 | 309 | 4 | DOID:0050453 (implicated_via_orthology) | |
| Disease | prostate carcinoma in situ (is_marker_for) | 1.98e-04 | 28 | 309 | 4 | DOID:8634 (is_marker_for) | |
| Disease | Parkinson's disease (implicated_via_orthology) | 2.62e-04 | 157 | 309 | 8 | DOID:14330 (implicated_via_orthology) | |
| Disease | Intellectual Disability | CDK16 HK1 BRWD3 BPTF KARS1 TRPM3 ASCC3 DYNC1H1 CACNA1E NDST1 ARMC9 KLHL15 STAG2 MAN1B1 | 2.95e-04 | 447 | 309 | 14 | C3714756 |
| Disease | urate measurement, bone density | RC3H1 ADGRB3 COL6A5 ERBIN ITPR2 DHX35 CPSF2 DNAH9 MTHFD1L GRID1 LCP1 TG PPP1R7 MAP4K5 KIAA1755 UGGT2 CRBN | 3.21e-04 | 619 | 309 | 17 | EFO_0003923, EFO_0004531 |
| Disease | picolinoylglycine measurement | 3.26e-04 | 3 | 309 | 2 | EFO_0800592 | |
| Disease | triacylglycerol 54:5 measurement | 3.37e-04 | 32 | 309 | 4 | EFO_0010423 | |
| Disease | angina pectoris | 3.59e-04 | 125 | 309 | 7 | EFO_0003913 | |
| Disease | Disorder of eye | 4.24e-04 | 212 | 309 | 9 | C0015397 | |
| Disease | Malignant neoplasm of breast | ABCA3 OBSCN CHEK1 FEM1C GDF10 PHB1 RGL1 ADHFE1 DNAH9 PLS3 FLT1 KALRN DYNC2H1 SMARCAL1 NUP98 LAMA2 CNNM4 THBS1 SLC39A12 NLRP14 IGF1R TRAPPC12 LONRF3 CLSPN | 4.43e-04 | 1074 | 309 | 24 | C0006142 |
| Disease | hematocrit | HK1 ADGRV1 FABP6 ITPR2 PHB1 SNX30 CHRDL1 GNA12 TRIM46 CACNA1C DPEP1 VLDLR ANKFY1 KALRN IFT81 HKDC1 HID1 SLC4A1 ARHGEF40 MAP4K5 ARID2 ANKRD17 PKN2 | 4.56e-04 | 1011 | 309 | 23 | EFO_0004348 |
| Disease | triacylglycerol 52:5 measurement | 4.78e-04 | 35 | 309 | 4 | EFO_0010417 | |
| Disease | triacylglycerol 52:4 measurement | 5.33e-04 | 36 | 309 | 4 | EFO_0010416 | |
| Disease | cholesteryl esters to total lipids in very large HDL percentage | 5.33e-04 | 36 | 309 | 4 | EFO_0022257 | |
| Disease | triglycerides in small LDL measurement | 6.03e-04 | 65 | 309 | 5 | EFO_0022323 | |
| Disease | juvenile-onset Parkinson's disease (implicated_via_orthology) | 6.47e-04 | 4 | 309 | 2 | DOID:0060893 (implicated_via_orthology) | |
| Disease | Kufor-Rakeb syndrome (implicated_via_orthology) | 6.47e-04 | 4 | 309 | 2 | DOID:0060556 (implicated_via_orthology) | |
| Disease | Megacystis microcolon intestinal hypoperistalsis syndrome | 6.47e-04 | 4 | 309 | 2 | C1608393 | |
| Disease | Psychotic Disorders | 6.92e-04 | 101 | 309 | 6 | C0033975 | |
| Disease | bipolar I disorder | 7.38e-04 | 141 | 309 | 7 | EFO_0009963 | |
| Disease | retinitis pigmentosa (is_implicated_in) | 8.80e-04 | 41 | 309 | 4 | DOID:10584 (is_implicated_in) | |
| Disease | immature platelet count | 8.92e-04 | 106 | 309 | 6 | EFO_0803544 | |
| Disease | free cholesterol to total lipids in IDL percentage | 1.06e-03 | 43 | 309 | 4 | EFO_0022278 | |
| Disease | cholesteryl esters to total lipids in small HDL percentage | 1.06e-03 | 43 | 309 | 4 | EFO_0022254 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 1.06e-03 | 43 | 309 | 4 | EFO_0022290 | |
| Disease | fasting blood glucose measurement, glucose tolerance test, fasting blood insulin measurement | 1.07e-03 | 5 | 309 | 2 | EFO_0004307, EFO_0004465, EFO_0004466 | |
| Disease | megacystis-microcolon-intestinal hypoperistalsis syndrome (is_implicated_in) | 1.07e-03 | 5 | 309 | 2 | DOID:0060610 (is_implicated_in) | |
| Disease | preeclampsia, fetal genotype effect measurement | 1.07e-03 | 5 | 309 | 2 | EFO_0000668, EFO_0007959 | |
| Disease | esophageal disease | 1.07e-03 | 5 | 309 | 2 | EFO_0009544 | |
| Disease | paraplegia (biomarker_via_orthology) | 1.07e-03 | 5 | 309 | 2 | DOID:607 (biomarker_via_orthology) | |
| Disease | marginal zone B-cell lymphoma, systemic lupus erythematosus | 1.07e-03 | 5 | 309 | 2 | EFO_1000630, MONDO_0007915 | |
| Disease | hyperinsulinemic hypoglycemia (implicated_via_orthology) | 1.07e-03 | 5 | 309 | 2 | DOID:13317 (implicated_via_orthology) | |
| Disease | insulin-like growth factor-binding protein 1 measurement | 1.07e-03 | 5 | 309 | 2 | EFO_0020474 | |
| Disease | coronary artery disease, factor VII measurement | 1.13e-03 | 111 | 309 | 6 | EFO_0001645, EFO_0004619 | |
| Disease | factor VIII measurement, coronary artery disease | 1.24e-03 | 113 | 309 | 6 | EFO_0001645, EFO_0004630 | |
| Disease | free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 1.32e-03 | 21 | 309 | 3 | EFO_0022277 | |
| Disease | unipolar depression, bipolar disorder | 1.33e-03 | 156 | 309 | 7 | EFO_0003761, MONDO_0004985 | |
| Disease | platelet measurement | DENND2D FABP6 TRPM3 PURB TBC1D14 PLEC KALRN YIF1B MAP4K5 RCL1 | 1.92e-03 | 315 | 309 | 10 | EFO_0005036 |
| Disease | triacylglycerol 58:7 measurement | 1.96e-03 | 24 | 309 | 3 | EFO_0010441 | |
| Disease | diacylglycerol 34:1 measurement | 1.96e-03 | 24 | 309 | 3 | EFO_0010352 | |
| Disease | cholesterol to total lipids in small HDL percentage | 2.00e-03 | 51 | 309 | 4 | EFO_0022240 | |
| Disease | Parkinson Disease | 2.02e-03 | 85 | 309 | 5 | C0030567 | |
| Disease | uric acid measurement | CNNM2 SIPA1L3 ADGRV1 PHB1 ANKRD28 RFT1 ANAPC4 TRIM46 DPEP1 DYNC2H1 NTRK1 IFT81 CRB1 IGF1R MAP4K5 | 2.11e-03 | 610 | 309 | 15 | EFO_0004761 |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 2.13e-03 | 86 | 309 | 5 | EFO_0008595, EFO_0020945 | |
| Disease | Cardiac Arrhythmia | 2.21e-03 | 25 | 309 | 3 | C0003811 | |
| Disease | Congenital Pain Insensitivity | 2.22e-03 | 7 | 309 | 2 | C0002768 | |
| Disease | Adenine measurement | 2.22e-03 | 7 | 309 | 2 | EFO_0021573 | |
| Disease | Lymphopenia | 2.22e-03 | 7 | 309 | 2 | C0024312 | |
| Disease | age of onset of anorexia nervosa | 2.22e-03 | 7 | 309 | 2 | OBA_2050099 | |
| Disease | group XIIB secretory phospholipase A2-like protein measurement | 2.22e-03 | 7 | 309 | 2 | EFO_0801657 | |
| Disease | MASA syndrome (implicated_via_orthology) | 2.22e-03 | 7 | 309 | 2 | DOID:0060246 (implicated_via_orthology) | |
| Disease | diabetes mellitus (implicated_via_orthology) | 2.47e-03 | 26 | 309 | 3 | DOID:9351 (implicated_via_orthology) | |
| Disease | Schizophrenia | CDK16 CNNM2 HK1 CHEK1 ADARB1 PHB1 PLAA TRPM1 MSS51 MAGEC1 CACNA1C VLDLR NTRK1 LAMA2 GRID1 THBS1 VPS35 PAH BECN1 | 2.62e-03 | 883 | 309 | 19 | C0036341 |
| Disease | triglycerides in medium VLDL measurement | 2.64e-03 | 55 | 309 | 4 | EFO_0022155 | |
| Disease | alcohol dependence measurement | 2.64e-03 | 55 | 309 | 4 | EFO_0007835 | |
| Disease | cholesterol to total lipids in large HDL percentage | 2.64e-03 | 55 | 309 | 4 | EFO_0022234 | |
| Disease | platelet component distribution width | FABP6 TRPM3 PURB TBC1D14 ANKRD28 PDS5A GNA12 PLEC PLS3 CACNA1C KALRN HEATR4 SCGN LCP1 IGF1R PKN2 LRRC71 | 2.75e-03 | 755 | 309 | 17 | EFO_0007984 |
| Disease | isoleucine measurement | 2.82e-03 | 56 | 309 | 4 | EFO_0009793 | |
| Disease | vascular endothelial growth factor measurement | 2.82e-03 | 56 | 309 | 4 | EFO_0004762 | |
| Disease | triglycerides in LDL measurement | 2.82e-03 | 56 | 309 | 4 | EFO_0022320 | |
| Disease | cholesterol to total lipids in large LDL percentage | 2.82e-03 | 56 | 309 | 4 | EFO_0022235 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 2.82e-03 | 56 | 309 | 4 | EFO_0022279 | |
| Disease | cholesteryl esters to total lipids in large VLDL percentage | 2.82e-03 | 56 | 309 | 4 | EFO_0022250 | |
| Disease | urinary albumin to creatinine ratio | 2.90e-03 | 179 | 309 | 7 | EFO_0007778 | |
| Disease | Congenital Amaurosis of Retinal Origin | 2.94e-03 | 8 | 309 | 2 | C3540662 | |
| Disease | level of Triacylglycerol (53:4) in blood serum | 2.94e-03 | 8 | 309 | 2 | OBA_2045166 | |
| Disease | Hereditary spherocytosis | 2.94e-03 | 8 | 309 | 2 | C0037889 | |
| Disease | holoprosencephaly (is_implicated_in) | 2.94e-03 | 8 | 309 | 2 | DOID:4621 (is_implicated_in) | |
| Disease | sialic acid-binding Ig-like lectin 12 measurement | 2.94e-03 | 8 | 309 | 2 | EFO_0802066 | |
| Disease | language measurement | 2.94e-03 | 134 | 309 | 6 | EFO_0007797 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 3.01e-03 | 57 | 309 | 4 | EFO_0022284 | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 3.07e-03 | 28 | 309 | 3 | DOID:4194 (implicated_via_orthology) | |
| Disease | low density lipoprotein particle size measurement | 3.21e-03 | 58 | 309 | 4 | EFO_0008593 | |
| Disease | Colorectal Carcinoma | OMA1 ABCA3 MAP2 CFTR OBSCN FZD4 ABCC8 KRT20 TTLL10 ANAPC4 DPEP1 CAD KALRN MTHFD1L GRID1 SMTN | 3.22e-03 | 702 | 309 | 16 | C0009402 |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 3.28e-03 | 137 | 309 | 6 | EFO_0004611, EFO_0008591 | |
| Disease | neuroimaging measurement, brain volume measurement | 3.37e-03 | 286 | 309 | 9 | EFO_0004346, EFO_0006930 | |
| Disease | cholesteryl esters to total lipids in large HDL percentage | 3.41e-03 | 59 | 309 | 4 | EFO_0022248 | |
| Disease | free cholesterol to total lipids in very large VLDL percentage | 3.41e-03 | 59 | 309 | 4 | EFO_0022289 | |
| Disease | brain connectivity measurement | CNNM2 MAP2 ADGRV1 PNMA6F GNA12 PLEC DPEP1 SLF1 PPP4R3A THBS1 DAAM1 | 3.52e-03 | 400 | 309 | 11 | EFO_0005210 |
| Disease | amyotrophic lateral sclerosis (implicated_via_orthology) | 3.75e-03 | 30 | 309 | 3 | DOID:332 (implicated_via_orthology) | |
| Disease | gamma-glutamylisoleucine measurement | 3.75e-03 | 9 | 309 | 2 | EFO_0021139 | |
| Disease | triglyceride measurement, blood pressure | 3.75e-03 | 9 | 309 | 2 | EFO_0004325, EFO_0004530 | |
| Disease | triglycerides in small VLDL measurement | 3.85e-03 | 61 | 309 | 4 | EFO_0022145 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 3.85e-03 | 61 | 309 | 4 | EFO_0008317, EFO_0008596, EFO_0020946 | |
| Disease | phospholipids in HDL measurement | 3.85e-03 | 61 | 309 | 4 | EFO_0022293 | |
| Disease | phospholipids in large VLDL measurement | 4.08e-03 | 62 | 309 | 4 | EFO_0022169 | |
| Disease | triglycerides in medium LDL measurement | 4.08e-03 | 62 | 309 | 4 | EFO_0022322 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 4.08e-03 | 62 | 309 | 4 | EFO_0022339 | |
| Disease | free cholesterol in very large HDL measurement | 4.08e-03 | 62 | 309 | 4 | EFO_0022273 | |
| Disease | cholesteryl esters to total lipids in large LDL percentage | 4.11e-03 | 31 | 309 | 3 | EFO_0022249 | |
| Disease | osteoporosis (is_implicated_in) | 4.11e-03 | 31 | 309 | 3 | DOID:11476 (is_implicated_in) | |
| Disease | electrocardiography | OMA1 MYH11 OBSCN HMCN2 TRPM3 PLEC CACNA1C ARMC9 RADIL IGF1R CTNNA3 KIAA1755 CNOT1 | 4.18e-03 | 530 | 309 | 13 | EFO_0004327 |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 4.19e-03 | 144 | 309 | 6 | EFO_0004611, EFO_0020943 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLFGLIALAEEVRKL | 481 | Q9UMD9 | |
| LLARGIDFKGVNLVI | 471 | Q9Y2R4 | |
| NFGRLTKLQILELRE | 156 | Q96RT1 | |
| RLVQFDSGKLEALAI | 1891 | Q96L91 | |
| ELDQSLFRGRVIKVL | 206 | A6NDY0 | |
| ILSTRFFDIQLGIKD | 186 | Q9UM22 | |
| IELFDKLSLRFNGRV | 186 | Q9H3F6 | |
| ETQLSFLRGEKILIL | 46 | P55345 | |
| LKIEVLIDLRFFSEA | 2116 | Q96N23 | |
| LAREKVESELTFLGL | 676 | Q4VNC0 | |
| FLDIKALGERTLSAL | 1396 | Q8TER5 | |
| KRDLIALANTAGEVL | 31 | Q9UJX5 | |
| ALREKTLALGSVQLD | 496 | Q8IVF6 | |
| GILNRFSKDIAILDD | 971 | P13569 | |
| EFRQGLAKLGLVLDQ | 131 | Q13938 | |
| FADAQLVLTRKDLLF | 1051 | Q6UVK1 | |
| LALGLALEKFEEERI | 836 | Q15878 | |
| LLLDERDNLKISDFG | 136 | O14757 | |
| ILSELTFLEVEQGKR | 871 | Q68DQ2 | |
| LSDFKQVLLREGIQA | 721 | Q9P2I0 | |
| KSLFLDLVELQRGLA | 371 | O15254 | |
| RRVFTKGTVLLDLQE | 111 | P02730 | |
| ILVFNKLVSRDGILD | 1041 | O60242 | |
| GLSFAKRLQQLIEVL | 381 | P10323 | |
| LLINERGELKLADFG | 271 | Q07002 | |
| IKAVFILDNDGRRLL | 46 | Q9P299 | |
| KEGILNISRRNDLIF | 571 | Q8WXG9 | |
| VILRNLSFEEGNVKL | 291 | Q68CP9 | |
| IIELLILSGARVNAK | 56 | O15084 | |
| LILAGRQKELVDALY | 751 | Q8IYW2 | |
| DDVLRIQLLKIGSAI | 291 | Q96SW2 | |
| LRSEALGDILQVAVK | 151 | A5YM72 | |
| LLAVDRLSLAVQKGE | 1396 | Q99758 | |
| AKIVTDVLLRFIGDQ | 1231 | Q6RI45 | |
| LIELFIVIGNKRAND | 751 | Q8WZ64 | |
| KNRIITAEGIILLFC | 141 | P11912 | |
| KDIQDQLERIFLVLG | 336 | O94921 | |
| LALSFATKERDGLLL | 1391 | Q9HCU4 | |
| DLLDAAKSVVRALFI | 236 | Q01433 | |
| FQGRTEVVSLLLDRK | 1261 | O75179 | |
| RAKIAIGLLEFVEEL | 271 | Q5VUD6 | |
| ATKAVLQEFGRIDIL | 121 | Q9Y394 | |
| EGVSRLFLKAQALLF | 326 | Q8IV53 | |
| DGALRLDQLKLAFTL | 546 | Q8IYB7 | |
| AKNRIVISEFGTLAL | 136 | Q9BYV7 | |
| LDGLLERRIKQFTLE | 1186 | Q12830 | |
| SDSRIIAGLVLQKDF | 231 | Q8TAM1 | |
| VLDTNDRFLRKITIG | 576 | Q6UB35 | |
| AQVTKLGEEVSLRFL | 226 | A6NI56 | |
| REFKVGALRQELATL | 496 | A6NI56 | |
| GERKQFAVVLLSLRL | 621 | Q8IWY9 | |
| NIILGGKLAALEEFR | 141 | Q5JU67 | |
| ALGKILLSTLDAFRD | 536 | Q9HA90 | |
| QIKLELTFRELIGSF | 801 | Q96BY7 | |
| LEVAEQRKLLFTGLV | 1261 | Q149M9 | |
| ILKSVVARFDAGELI | 126 | P35232 | |
| QGLLIDLLIKSDVSR | 241 | P26374 | |
| FIRLLDKITNGSRIE | 51 | Q9Y2P8 | |
| LALEDGSALSRKVLV | 206 | Q9HBD1 | |
| LEDGSALSRKVLVLF | 211 | Q5TC82 | |
| IFLFITRQLKGLEDT | 116 | Q29RF7 | |
| QVLTLLLNKFRVEDG | 201 | Q9H2L5 | |
| IRSENFEELLKVLGV | 11 | P29373 | |
| LNAFILRFLSKEIVG | 31 | Q96AA3 | |
| RGFASTKEVLELLLD | 101 | Q9NZL6 | |
| ILEEGSFLLAELRKT | 146 | P24903 | |
| QELRLLLAGAEVQAK | 46 | Q96HZ4 | |
| IKGIFLLNRTALFEV | 196 | Q6IN85 | |
| DSFVEEGNTLRKILL | 1686 | Q14571 | |
| GELLLRQKLDFESIQ | 301 | Q9Y5E7 | |
| FGQLLLKIARLIRET | 456 | Q96JH8 | |
| IVRNLLLAGAKVNEL | 921 | Q9P2R3 | |
| KTERINALELLGATF | 241 | Q96JP0 | |
| GELRNLTIVKSGLRF | 91 | P04629 | |
| IALSNILERVKAEGL | 641 | P23469 | |
| ILERVKAEGLLDVFQ | 646 | P23469 | |
| IQDERLRIFALLAGK | 1391 | P52948 | |
| ADLKGLLQRLETVSE | 121 | Q6N063 | |
| IKLIDFGLARRLENA | 1601 | Q15746 | |
| LLLDKDCTVLVGRQL | 51 | Q9NU22 | |
| LFLEGKERVLAAVQA | 5501 | Q9NU22 | |
| EGLLQALTRKLEAVS | 471 | P21941 | |
| QRTELVFGLALKEVN | 156 | O15481 | |
| RKAREFIEILFGISL | 951 | O60732 | |
| GRVLLKEILEQGLFS | 31 | Q9BUP3 | |
| ILSGRDLQFLLRETK | 496 | Q09328 | |
| DLQFLLRETKLFVGL | 501 | Q09328 | |
| RLVSSEQALKELGLA | 491 | Q5TA45 | |
| QGEDLRKFILAALSA | 376 | Q9UBI9 | |
| DVLQGSLKRLLTDVL | 226 | Q4VC12 | |
| AIKSGNEDIAIFLLR | 201 | Q38SD2 | |
| SLAKELIFSARVLDG | 231 | Q13825 | |
| SIRAILFLGEKEAAL | 661 | Q5JYT7 | |
| LAQTLEKLGFVVGRL | 221 | Q9Y2Z2 | |
| LTLASILREDGKVFD | 156 | Q9Y5Z4 | |
| TLRISKVQLADAGIF | 3376 | Q8NDA2 | |
| ILGSDRLKAFLLQAL | 326 | Q7Z3E5 | |
| GLLDLELNRLTKALF | 371 | O43861 | |
| ELNRLTKALFLALVA | 376 | O43861 | |
| FLFSKEGSIILDAIR | 766 | Q9BZQ6 | |
| NLSRRLKVTGDLFDI | 111 | Q14457 | |
| LGVLFLDENRNVVLK | 451 | P55107 | |
| FLKNLRLILGEEQLE | 401 | P08069 | |
| REALLNFTLDVDVGK | 721 | P38570 | |
| DLFSALGDAKRQLEI | 581 | Q8N5G2 | |
| VIKIGLFADIELSRN | 231 | P13796 | |
| KIGLFADIELSRNEA | 236 | P13797 | |
| DLDVRVKAVLLGATF | 261 | Q9NRY6 | |
| AFVVRLEGLLQKAVE | 356 | A0A0J9YX94 | |
| FRAGALQLLLVGDKV | 281 | P55058 | |
| SLEDEIVGRLLKILF | 16 | P0DMT0 | |
| EFVFLGLSDSRKIQL | 11 | Q8NGB9 | |
| EFEELLQTKTAGRLL | 126 | Q8NEN9 | |
| SLFLEVKELFLAAVR | 466 | P50542 | |
| ELLQLEFGEVRSQLK | 196 | O60658 | |
| VFVLGFSEELNKLLL | 86 | Q86X83 | |
| LDGVVIELLFRQSKI | 646 | Q9Y2G0 | |
| IELLFRQSKISEVLG | 651 | Q9Y2G0 | |
| NGDRFIEEKTLLLAV | 136 | Q32MH5 | |
| TKELALGQDRILIRF | 86 | P30046 | |
| EQIVIFSELLRKGSL | 2151 | O60229 | |
| AVDQALKEFGRIDIL | 96 | Q9NUI1 | |
| DTFIRLIILGKDDEN | 1796 | Q6ZR08 | |
| DKIINGGELFLTVLL | 506 | P52848 | |
| GALKLAEVLRAFELT | 296 | Q8N4P6 | |
| FLRRLQVLKSTGDVA | 621 | Q9NY33 | |
| KEGTFQGLISLRILD | 381 | Q9BXB1 | |
| LEVNFAKALELRGVQ | 3101 | P24043 | |
| ILAQARKILFVIDGF | 276 | Q9NX02 | |
| IIELLILSGARVNAK | 56 | Q8N8A2 | |
| RLDSEGIELITKFLQ | 441 | Q00537 | |
| ILGFQVEDALALIRL | 141 | Q9NRX1 | |
| EIIRGILFLNKATLF | 196 | Q5MIZ7 | |
| KEENLVRRTLFITGL | 221 | O94886 | |
| QVLADAVSRLVLGKF | 321 | P78563 | |
| LDLGGTNFRVLLVKI | 531 | P19367 | |
| RLTVEADLQGLNKVF | 166 | P35900 | |
| FRAQEIDGQALLLLK | 941 | Q8NDX5 | |
| GELKRLLEQEFADVI | 31 | Q9UBG3 | |
| KAGLTLETRLQIALD | 746 | Q6XUX3 | |
| GALAKVLRLFEENDV | 46 | P00439 | |
| IQLEFRELSRLTGDK | 401 | Q9UKM7 | |
| EILTLARLFVKEGID | 106 | Q9NZB8 | |
| LLESVLQELKGLQEF | 706 | O75694 | |
| NVFELKTRQGTELLI | 541 | Q8IWW6 | |
| FQELGLKNVVISRLL | 156 | Q49AM1 | |
| QISLLGFRDLVLLKV | 156 | Q6MZQ0 | |
| GLLDQFETRKTLILI | 6526 | Q5VST9 | |
| ALDESLFRGRQIKVI | 231 | Q86U42 | |
| TILVERDGKFELLNL | 216 | Q5TID7 | |
| EKRLEAIISGAALLA | 301 | Q9UI47 | |
| RSGALKQLLEVVLAF | 806 | Q9Y4D1 | |
| IAAGLVALFKIRSNL | 406 | Q9ULV1 | |
| EKLLFGDLLRVADTI | 1226 | Q8NCM8 | |
| LALRNITDTGFKLLL | 1106 | Q9NQ11 | |
| FVGDATRLTDKLLEL | 2211 | Q13535 | |
| FLDQLARLGVISKVS | 611 | Q9ULT8 | |
| AARLKALSFLVLLED | 166 | Q14674 | |
| QIIAELKAEFGLLQR | 416 | Q8WYA0 | |
| LKAEFGLLQRTEELL | 421 | Q8WYA0 | |
| NIEGVREKLDTFLLD | 146 | Q96M94 | |
| LALRDSGILFDVVLV | 41 | Q53GT1 | |
| VGLDQRFSLKQIEAL | 166 | O95352 | |
| LSDGDIKLLVNIVRA | 1036 | Q9P2K1 | |
| VTSLDQLKGLALVDR | 301 | Q9BVC3 | |
| FALVRTALRIKTEGN | 1611 | Q13936 | |
| AVLDIREFKGLRFIQ | 461 | Q9Y6W3 | |
| LLFFLLLEGGKTEQV | 16 | Q9BU40 | |
| GLFERDKLIFLAQVT | 3721 | Q9UFH2 | |
| DLLTKLLQFEGRNRI | 421 | Q00536 | |
| GERAKQLLRFAIATL | 121 | P20853 | |
| ILQLKALGIDNVLRF | 431 | Q9H5Z1 | |
| LLGISSDVIEKARNF | 21 | P51161 | |
| LIALIVEQLKSRGLF | 51 | Q96IK1 | |
| DTALELRNKGITIFA | 936 | A8TX70 | |
| KFGDFITLANREVLL | 16 | Q14534 | |
| ILALKLQGDRVRDTF | 821 | Q86WZ0 | |
| ELLKGNETIARLQAL | 446 | Q6ZUT9 | |
| TIFDNILKGSRVLVD | 96 | Q03113 | |
| DAQLIKELGLRLLYA | 61 | O95571 | |
| SDKLRQILEIVLAFG | 831 | O95466 | |
| ILARAAELFVETIAK | 66 | Q9NR33 | |
| GEFQLRLRQLEKSLL | 3736 | Q14204 | |
| GELISKRADLAISAI | 506 | Q9ULK0 | |
| TEAEDKSIRLGLFLI | 11 | Q86W47 | |
| TIEAANLAGLKILRV | 186 | P48723 | |
| TLLKLQEIGLGAFER | 346 | Q32P44 | |
| RFLVLINDLLASGEI | 2891 | Q9NYC9 | |
| EALLSGDLEKFSRVL | 161 | Q5TDH0 | |
| NSADLRLVKTFIELG | 1151 | Q49AJ0 | |
| RSNRDVFVKLELLSG | 526 | P82279 | |
| FELAKRGLNVVLISR | 66 | P37058 | |
| AEVKGALADNLLRVF | 336 | P16444 | |
| FNLLRNIEGVDKLTR | 151 | Q15435 | |
| GLRLKSIDNGIFVQL | 126 | O00560 | |
| SISGVDLDKFREILL | 236 | O76038 | |
| AFAAGILESKRLNLV | 416 | Q8N697 | |
| FSARQLVEIFLQKGL | 311 | Q504Y0 | |
| GAFITLVARNEDKLL | 56 | Q06136 | |
| NFLRTKELDLRGVSI | 76 | Q9Y597 | |
| GVADLKEILNAILNR | 846 | P54277 | |
| TLFLTDEEKRLLGQE | 186 | Q8TEY5 | |
| FTDERLQGLLQVELK | 216 | Q8N5C7 | |
| FEVLAFKNRTLGLID | 311 | Q9Y661 | |
| NIRKFLILITDGEAQ | 721 | A6NMZ7 | |
| QIFASAVLERKIIFL | 246 | Q9H6A0 | |
| AVLERKIIFLAEGLS | 251 | Q9H6A0 | |
| AQGLIEFRDALAKLI | 176 | Q96QR8 | |
| AVRDFSILINLIKVF | 1271 | Q9BXW9 | |
| RGLEANIFLKVLDIS | 241 | Q6ZQY2 | |
| QAKLGREVSRILLFF | 101 | Q5J8X5 | |
| GLSRALAVELLDKVN | 281 | Q9Y4K4 | |
| AQLLLLEIIEFRAAG | 191 | A9UHW6 | |
| DNRIVLNGIDLKAFL | 731 | O15294 | |
| NGILFVNSRIDREKL | 81 | Q9UN75 | |
| QDLEREFLIKLGLVN | 1001 | Q9HAU5 | |
| IQDAGLVLADTLRKF | 396 | Q8IWW8 | |
| QFETSLELRKIGVRL | 416 | Q6ZN16 | |
| RVGLAALIIQDFKGL | 426 | Q5T160 | |
| LFVDRKLQRVGIFLD | 236 | O75677 | |
| DLFTDAIKLNPRLAI | 131 | Q8IZP2 | |
| GAVLEEKRASLLQAI | 321 | Q7Z4K8 | |
| GEEKRIFLDIQFLNL | 661 | Q9BYH1 | |
| ALRLTLLVGFEDVRK | 351 | Q8IYR2 | |
| EAVRLFLALQALEGA | 266 | Q7Z736 | |
| ASTLAEVERLKGLLQ | 211 | P09661 | |
| ARLLDKLVGEFLEVT | 441 | Q15046 | |
| ITELLQASGKIRLLD | 156 | Q1RMZ1 | |
| ISGAFLVLVKELNAR | 261 | Q7LBE3 | |
| LDLGGTNFRVLLVKI | 531 | Q2TB90 | |
| LDSLIELDLRGNKFE | 156 | Q8N0V4 | |
| EFIEGTLANKEILRL | 171 | P35243 | |
| AKLSRQFFIGILDIT | 461 | Q9Y2K3 | |
| FLGQLEAIRDERLSK | 781 | Q9Y2K3 | |
| LREAEEKSLLVGFSL | 71 | Q9NPR9 | |
| EDFQFILKGIARLLS | 336 | Q8IV36 | |
| FLQLGREDQIALLKA | 291 | P55055 | |
| KDRLTAGLINIVSFD | 516 | Q9NZC9 | |
| GISNEFVVLLDLRTK | 891 | O60292 | |
| QASEKELLIAGRIFV | 416 | Q9NY91 | |
| TVRNLALGDKFLLRV | 131 | Q13203 | |
| QRILFVVDGLDELKV | 246 | Q8WX94 | |
| LGLEKTFAEARLISA | 631 | Q6IE81 | |
| ALEQLADGKLRFVVE | 361 | Q9BUU2 | |
| RDLKLDNLLLDTEGF | 781 | Q16513 | |
| SVAFLRVIGDQLEKL | 116 | A6NNN8 | |
| GDDLRQELLAFQVLK | 566 | Q9UBF8 | |
| IIDLFKNIFQLVGLD | 351 | A4QPH2 | |
| LVFLKTDNLEVILLG | 326 | Q5PT55 | |
| VFRALILGELEKGQS | 81 | Q86UD1 | |
| LLLGKEQFRLLSELE | 226 | Q96E52 | |
| RIFLLGLADNEAAIV | 311 | Q9UHB9 | |
| EKVASIALLDLTGAR | 3581 | Q9NRC6 | |
| VDFGLSRILKNSEEL | 206 | Q9UEE5 | |
| SFLKLTLGLVNEDVR | 886 | Q8TEV9 | |
| DLVIVLKRGAILEFD | 1546 | Q09428 | |
| FLILGEVDKRELIAL | 2116 | Q8N3C0 | |
| RNKVLIFGILEETLL | 956 | Q13733 | |
| LAVRSNLAGAEKLFV | 351 | P53675 | |
| RFTLDRLKQLGVDVS | 491 | Q9HAW4 | |
| GERSNIVDLLFVKDL | 486 | Q9H8M5 | |
| SKLLDFFLGQEIRTV | 321 | Q6P4Q7 | |
| QGILKTDDLITRFFR | 1886 | A5YKK6 | |
| RSGKLDAFLVLEQLR | 686 | P35749 | |
| RELGVLVFENSAKRL | 426 | Q92759 | |
| KLALVEENGIFELLR | 396 | Q9Y446 | |
| DKLARNGVFLASELE | 941 | Q96JI7 | |
| FRTALGILKLFEDIL | 616 | Q9P2M4 | |
| LNERFGILKEQRATL | 291 | Q96QD9 | |
| DFLEELKLVVRGSLF | 181 | P35443 | |
| ELLDLRGNKLLFLTD | 691 | Q9NR97 | |
| TLRLKILADAAAEGV | 266 | Q5BJH7 | |
| FLKRDNLLIADIELG | 331 | P43403 | |
| FRAQEIDGQALLLLK | 816 | Q8IXK0 | |
| QDLVDAVRAEKGFLL | 76 | P07996 | |
| RAVFQAVLELTLGKA | 296 | Q6ZTK2 | |
| LALKVILVCFERQLG | 2796 | Q8N2C7 | |
| FTLKDILLGDREISA | 56 | Q0ZLH3 | |
| TFALKLGTIDRIAQR | 251 | Q5VWJ9 | |
| RLALLVKLGLFQNAE | 431 | Q8WVT3 | |
| ALTFGLDQLKTREAI | 956 | Q8N3U4 | |
| KNIIIALIDRLALFA | 296 | Q96QK1 | |
| VLQDLGDFLAAKRAL | 251 | Q96HA7 | |
| LDRVDFVKLLIENGV | 521 | Q9HCF6 | |
| LLTGLISFREKRLQD | 766 | O94759 | |
| ALLLRLFTIGGVQKE | 551 | O75717 | |
| LDSVGQKLLFLTRET | 426 | Q96IC2 | |
| QKLLFLTRETDAGEL | 431 | Q96IC2 | |
| ILRALSNFIKDAVLF | 186 | P47872 | |
| ILLRNGVSEENLAKL | 411 | Q15833 | |
| EGIKVIFQLALAVLD | 701 | Q6ZT07 | |
| VQDLEATFRLLVALG | 736 | Q9Y263 | |
| EGFRQISLNKVAVLL | 96 | Q3KQV9 | |
| GIFEELLRKAENSRL | 886 | Q9HBJ7 | |
| LRISKFLGLDEEQSV | 76 | Q5SRE5 | |
| IFSLIFKLEELRAAL | 126 | Q9NQQ7 | |
| LLAELEGKLRVFENI | 186 | Q13077 | |
| TEQLLRDKALGSFLI | 61 | A6NKC9 | |
| DEILKLGLFSNRFLE | 376 | Q9P0W8 | |
| AVIADLGLIRVENKF | 1776 | Q709C8 | |
| LDFALLQKVRAEIAS | 166 | Q13123 | |
| LLVDRKLQRVGIFLD | 236 | O75679 | |
| LLVDLRSGELKLIDF | 176 | Q86V86 | |
| IRLLFNDVQTLKDGR | 586 | Q15149 | |
| VLAEKLAAIGEATRL | 1971 | Q15149 | |
| TLRILALEKLGAVFN | 761 | Q15393 | |
| SLIRVLEAGKANVIL | 141 | Q9BQI6 | |
| ENRFKFSRLLDTIGI | 1046 | P27708 | |
| IVSVRLFQDGEKRLA | 66 | Q969S6 | |
| LFQDGEKRLAVLRLF | 71 | Q969S6 | |
| DLSLIEVKLAAAGRV | 911 | P11137 | |
| LDRVDFVKLLIENGV | 471 | Q7Z4N2 | |
| LKLELITAEAEGNRL | 441 | Q9BZW7 | |
| RELLLGKDFLNVTTE | 586 | O43296 | |
| QGLLIFAELISAIKR | 281 | Q96K49 | |
| EGKLSLLVLRDRGQF | 261 | O95049 | |
| AQLGALFILKESAER | 111 | Q6NXT4 | |
| LAVEGALSLEEKLAR | 551 | Q96AP4 | |
| FRALGISISLEQAEK | 106 | Q9BV35 | |
| LKFILENLIERDSGV | 96 | A0A0C4DH27 | |
| KEIEAFDAAILLIRN | 406 | Q2TBF2 | |
| LRSFLGQLAKEEIAT | 806 | Q9NYU1 | |
| LSAEELEAIKLIRFG | 76 | Q9NX45 | |
| ILQKLVAAFGELRSL | 951 | A3KMH1 | |
| RFAELVEKLGDLLQA | 1146 | P17948 | |
| SFLVAKGIRLRNEDL | 956 | P01266 | |
| KGIFLLRNQEEVAAL | 321 | Q6ZVT0 | |
| VFFELNGQLRSILVK | 1076 | P11498 | |
| EGALRKLLEVTADLA | 11 | P53814 | |
| LFEAQGNDRLKLLVL | 811 | Q9H3U1 | |
| QGALILAELLSAVKR | 291 | Q8NBN3 | |
| GQDRRIVLKSLEFLA | 631 | P98155 | |
| SLELADRILLAVKEF | 126 | Q8IZS6 | |
| ELKILDFGLARQADS | 166 | P53778 | |
| ELAAKESLIFGLRTE | 751 | Q9C099 | |
| LATLGKVEEALREFL | 321 | Q496Y0 | |
| FLFGLLNEDRVKQLE | 531 | Q86W24 | |
| FKLILVGFERLQAIA | 806 | Q6PIF6 | |
| VAIAELVALFLEGLK | 1486 | Q6PIF6 | |
| LVALFLEGLKERSIF | 1491 | Q6PIF6 |